Scholars@Duke

• Background
• 

  Education, Training, & Certifications

  • Fellowship, Urologic Oncology, Johns Hopkins University 1997 - 1998
  • Assistant Chief of Service, Urology, Johns Hopkins University 1997
  • Chief Resident, Urology, Johns Hopkins University 1996 - 1997
  • Resident, Urology, Johns Hopkins University 1993 - 1996
  • Assistant Resident in General Surgery, Surgery, Johns Hopkins University 1992 - 1993
  • Intern in General Surgery, Surgery, Johns Hopkins University 1991 - 1992
  • M.D., The University of Chicago 1991
• 

  Previous Appointments & Affiliations

  • Associate Professor of Surgery, Surgery, Urology, Surgery 2009 - 2011
  • Associate Professor of Surgery, Surgery, Urology, Surgery 2003 - 2009
  • Assistant Professor of Surgery, Surgery, Urology, Surgery 2001 - 2003
  • Assistant Clinical Professor of Surgery, Surgery, Urology, Surgery 1998 - 2001
• Recognition
• 

  In the News

  • JAN 5, 2015

    WRAL

    New imaging detects more prostate tumors
• Research
• 

  Selected Grants

  • An Extension Study of MRI/US Fusion Imaging and Biopsy in Combination with Nanoparticle Directed Focal Therapy for Ablation of Prostate Tissue awarded by Nanospectra Biosciences, Inc. 2020 - 2023
  • Image guided targeted biopsy of clinically significant prostate cancer with acoustic radiation force awarded by National Institutes of Health 2010 - 2022
  • Development of a combined ARFI/SWEI ultrasound elasticity imaging system for targeted prostate biopsy guidance awarded by National Institutes of Health 2021 - 2022
  • Early Detection of Clinically Significant Prostate Cancer using Ultrasonic Acoustic Radiation Force Impulse (ARFI) Imaging awarded by United States Army Medical Research Acquisition Activity 2016 - 2019
  • Prospective registry to optimize clinical care (DUCIMAS) awarded by Myriad Genetics, Inc. 2016 - 2019
  • A Phase 3 Study to Evaluate the Safety and Efficacy of Tc-MIP-1404 SPECT/CT Imaging to Detect Clinically Significant Prostate Cancer in Men with Biopsy Proven Low-Grade Prostate Cancer who are Candidates for Active Surveillance(proSPECT-AS) awarded by Molecular Insight Pharmaceuticals, Inc. 2016 - 2019
  • A Pilot Study in Human Subjects Evaluating the Use of the NanoKnife System for Ablation of Prostate Cancer Tissue in a Low Risk Patient Population awarded by AngioDynamics 2014 - 2018
  • Prostate Cancer Assessment and Treatment Guidance Via Integrated 3D ARFI Elasticity Imaging and Multi-Parametric MRI awarded by Kitware Inc. 2015 - 2016
  • Evaluation of Sexual Function after Primary and Salvage Prostate Cryoablation for Localized Prostate Cancer awarded by Josiah Charles Trent Memorial Foundation 2010 - 2011
  • Trent Foundation Grant awarded by Josiah Charles Trent Memorial Foundation 2006 - 2009
  • Psychobiology of male sexual dysfunction following treatment of prostate cancer awarded by Josiah Charles Trent Memorial Foundation 2002 - 2003
• 

  External Relationships

  • AngioDynamic
  • Duke PDC
  • Durham VA Medical Center
• Publications & Artistic Works
• 

  Selected Publications

  • Books

    • Polascik, T. J. Preface, 2013. https://doi.org/10.1007/978-1-62703-182-0.
       Full Text

  • Academic Articles

    • Arcot, Rohith, and Thomas J. Polascik. “Evolution of Focal Therapy in Prostate Cancer: Past, Present, and Future. (Accepted)” The Urologic Clinics of North America 49, no. 1 (February 2022): 129–52. https://doi.org/10.1016/j.ucl.2021.07.011.
       Full Text
    • Arcot, Rohith, and Thomas J. Polascik. “Editorial Comment.” J Urol 206, no. 5 (November 2021): 1182–83. https://doi.org/10.1097/JU.0000000000001934.01.
       Full Text  Link to Item
    • Tan, Wei Phin, Ardeshir R. Rastinehad, Laurence Klotz, Peter R. Carroll, Mark Emberton, John F. Feller, Arvin K. George, et al. “Utilization of focal therapy for patients discontinuing active surveillance of prostate cancer: Recommendations of an international Delphi consensus.” Urol Oncol 39, no. 11 (November 2021): 781.e17-781.e24. https://doi.org/10.1016/j.urolonc.2021.01.027.
       Full Text  Link to Item
    • Arcot, Rohith, Bradley A. Potts, and Thomas J. Polascik. “Focal Cryoablation of Image-Localized Prostate Cancer.” J Endourol 35, no. S2 (September 2021): S17–23. https://doi.org/10.1089/end.2021.0411.
       Full Text  Link to Item
    • Tan, Wei Phin, Andrew Chang, Christina Sze, and Thomas J. Polascik. “Oncological and Functional Outcomes of Patients Undergoing Individualized Partial Gland Cryoablation of the Prostate: A Single-Institution Experience.” J Endourol 35, no. 9 (September 2021): 1290–99. https://doi.org/10.1089/end.2020.0740.
       Full Text  Link to Item
    • Arcot, Rohith, Todd M. Morgan, and Thomas J. Polascik. “Genetically Informed Prostate Cancer Screening.” The Urologic Clinics of North America 48, no. 3 (August 2021): 373–86. https://doi.org/10.1016/j.ucl.2021.04.001.
       Full Text
    • Polascik, Thomas J. “Editorial Comment.” J Urol 206, no. 2 (August 2021): 336. https://doi.org/10.1097/JU.0000000000001771.01.
       Full Text  Link to Item
    • Chan, Derek Y., D Cody Morris, Thomas J. Polascik, Mark L. Palmeri, and Kathryn R. Nightingale. “Deep Convolutional Neural Networks for Displacement Estimation in ARFI Imaging.” Ieee Transactions on Ultrasonics, Ferroelectrics, and Frequency Control 68, no. 7 (July 5, 2021): 2472–81. https://doi.org/10.1109/tuffc.2021.3068377.
       Full Text
    • Morris, D Cody, Derek Y. Chan, Mark L. Palmeri, Thomas J. Polascik, Wen-Chi Foo, and Kathryn R. Nightingale. “Prostate Cancer Detection Using 3-D Shear Wave Elasticity Imaging.” Ultrasound Med Biol 47, no. 7 (July 2021): 1670–80. https://doi.org/10.1016/j.ultrasmedbio.2021.02.006.
       Full Text  Link to Item
    • ElShafei, Ahmed, Molly DeWitt-Foy, Adam Calaway, Austin J. Fernstrum, Adonis Hijaz, Wade Muncey, Anood Alfahmy, et al. “Does prior surgical interventional therapy for BPH affect the oncological or functional outcomes after primary whole-gland prostate cryoablation for localized prostate cancer?” Prostate Cancer Prostatic Dis 24, no. 2 (June 2021): 507–13. https://doi.org/10.1038/s41391-020-00306-z.
       Full Text  Link to Item
    • Shah, Ankeet, and Thomas J. Polascik. “Data-driven Focal Therapy for Localized Prostate Cancer: A Wake-up Call.” Eur Urol Oncol 4, no. 3 (June 2021): 424–25. https://doi.org/10.1016/j.euo.2021.01.008.
       Full Text  Link to Item
    • Taha, T., W. P. Tan, A. Elshafei, A. Aminsharifi, R. Given, M. L. Cher, and T. J. Polascik. “Does the type of cryoprobe affect oncological and functional outcomes in men with clinically localized prostate cancer treated with primary whole gland prostate cryoablation?” Current Urology 15, no. 2 (June 1, 2021): 79–84. https://doi.org/10.1097/CU9.0000000000000015.
       Full Text
    • Polascik, Thomas. “Prostate Cancer Focal Therapy Has Made Great Strides and the Future Remains Bright.” Oncology (Williston Park, N.Y.) 35, no. 5 (May 14, 2021): 269. https://doi.org/10.46883/onc.2021.3505.0269.
       Full Text
    • Zhao, Hanson, Lauren E. Howard, Amanda M. De Hoedt, Martha K. Terris, Christopher L. Amling, Christopher J. Kane, Matthew R. Cooperberg, et al. “Safety of concomitant therapy with radium-223 and abiraterone or enzalutamide in a real-world population.” Prostate 81, no. 7 (May 2021): 390–97. https://doi.org/10.1002/pros.24115.
       Full Text  Link to Item
    • Polascik, Thomas J. “Editorial Comment.” J Urol 205, no. 3 (March 2021): 798–99. https://doi.org/10.1097/JU.0000000000001382.02.
       Full Text  Link to Item
    • Tourinho-Barbosa, Rafael R., Bradford J. Wood, Andre Luis Abreu, Bruno Nahar, Toshitaka Shin, Selcuk Guven, and Thomas J. Polascik. “Current state of image-guided focal therapy for prostate cancer.” World J Urol 39, no. 3 (March 2021): 701–17. https://doi.org/10.1007/s00345-020-03254-4.
       Full Text  Link to Item
    • Rosette, Jean J. M. C. H. de la, Rafael Sanchez Salas, Art Rastinehad, and Thomas J. Polascik. “Imaging and technologies for prostate cancer. Where are we now-where do we go?” World J Urol 39, no. 3 (March 2021): 635–36. https://doi.org/10.1007/s00345-021-03641-5.
       Full Text  Link to Item
    • Arcot, Rohith, and Thomas J. Polascik. “Does MRI-guided TULSA provide a targeted approach to ablation?” Nat Rev Urol 18, no. 1 (January 2021): 5–6. https://doi.org/10.1038/s41585-020-00403-7.
       Full Text  Link to Item
    • Morris, D Cody, Derek Y. Chan, Theresa H. Lye, Hong Chen, Mark L. Palmeri, Thomas J. Polascik, Wen-Chi Foo, Jiaoti Huang, Jonathan Mamou, and Kathryn R. Nightingale. “Multiparametric Ultrasound for Targeting Prostate Cancer: Combining ARFI, SWEI, QUS and B-Mode.” Ultrasound Med Biol 46, no. 12 (December 2020): 3426–39. https://doi.org/10.1016/j.ultrasmedbio.2020.08.022.
       Full Text  Link to Item
    • Shah, Ankeet, and Thomas J. Polascik. “Editorial Comment on: "Ten-Year Experience with Percutaneous Cryoablation of Renal Tumors: Tumor Size Predicts Disease Progression" by Pickersgill et al.” J Endourol 34, no. 12 (December 2020): 1218. https://doi.org/10.1089/end.2020.0497.
       Full Text  Link to Item
    • Lebastchi, Amir H., Arvin K. George, Thomas J. Polascik, Jonathan Coleman, Jean de la Rosette, Baris Turkbey, Bradford J. Wood, et al. “Standardized Nomenclature and Surveillance Methodologies After Focal Therapy and Partial Gland Ablation for Localized Prostate Cancer: An International Multidisciplinary Consensus.” Eur Urol 78, no. 3 (September 2020): 371–78. https://doi.org/10.1016/j.eururo.2020.05.018.
       Full Text  Link to Item
    • Giri, Veda N., Karen E. Knudsen, William K. Kelly, Heather H. Cheng, Kathleen A. Cooney, Michael S. Cookson, William Dahut, et al. “Implementation of Germline Testing for Prostate Cancer: Philadelphia Prostate Cancer Consensus Conference 2019.” J Clin Oncol 38, no. 24 (August 20, 2020): 2798–2811. https://doi.org/10.1200/JCO.20.00046.
       Full Text  Link to Item
    • Nobuhara, Chloe K., W Michael Bullock, Thomas Bunning, Brian Colin, Mary Cooter, Michael J. Devinney, Michael N. Ferrandino, et al. “A protocol to reduce self-reported pain scores and adverse events following lumbar punctures in older adults.” J Neurol 267, no. 7 (July 2020): 2002–6. https://doi.org/10.1007/s00415-020-09797-1.
       Full Text  Link to Item
    • Westphalen, Antonio C., Charles E. McCulloch, Jordan M. Anaokar, Sandeep Arora, Nimrod S. Barashi, Jelle O. Barentsz, Tharakeswara K. Bathala, et al. “Variability of the Positive Predictive Value of PI-RADS for Prostate MRI across 26 Centers: Experience of the Society of Abdominal Radiology Prostate Cancer Disease-focused Panel.” Radiology 296, no. 1 (July 2020): 76–84. https://doi.org/10.1148/radiol.2020190646.
       Full Text  Link to Item
    • Tan, Wei Phin, Ahmed ElShafei, Alireza Aminsharifi, Ahmad O. Khalifa, and Thomas J. Polascik. “Salvage Focal Cryotherapy Offers Similar Short-term Oncologic Control and Improved Urinary Function Compared With Salvage Whole Gland Cryotherapy for Radiation-resistant or Recurrent Prostate Cancer.” Clin Genitourin Cancer 18, no. 3 (June 2020): e260–65. https://doi.org/10.1016/j.clgc.2019.11.009.
       Full Text  Link to Item
    • Tan, Wei Phin, Ariel A. Schulman, Gregory J. Barton, Christina Sze, and Thomas J. Polascik. “Renal Thermal Ablation Trends of American Urologists.” J Endourol 34, no. 4 (April 2020): 409–16. https://doi.org/10.1089/end.2019.0774.
       Full Text  Link to Item
    • Polascik, Thomas J. “Editorial Comment.” J Urol 203, no. 3 (March 2020): 560. https://doi.org/10.1097/JU.0000000000000541.02.
       Full Text  Link to Item
    • Zhao, Hanson, Lauren E. Howard, Amanda De Hoedt, Martha K. Terris, Christopher L. Amling, Christopher J. Kane, Matthew R. Cooperberg, et al. “Racial Discrepancies in Overall Survival among Men Treated with 223Radium.” J Urol 203, no. 2 (February 2020): 331–37. https://doi.org/10.1097/JU.0000000000000524.
       Full Text  Link to Item
    • Mayes, J. M., V. Mouraviev, L. Sun, J. F. Madden, and T. J. Polascik. “Retraction Note: Can the conventional sextant prostate biopsy reliably diagnose unilateral prostate cancer in low-risk, localized, prostate cancer? (Prostate Cancer and Prostatic Diseases, (2008), 10.1038/pcan.2008.31).” Prostate Cancer and Prostatic Diseases, January 1, 2020. https://doi.org/10.1038/pcan.2008.31z.
       Full Text
    • Tan, Wei Phin, and Thomas J. Polascik. “Re: Association of Black Race with Prostate Cancer-specific and Other-cause Mortality Dess RT, Hartman HE, Mahal BA, et al JAMA Oncol 2019;5:975-83.” European Urology 77, no. 1 (January 2020): 129–30. https://doi.org/10.1016/j.eururo.2019.08.036.
       Full Text
    • VanDusen, Keith W., Sarada Eleswarpu, Eugene W. Moretti, Michael J. Devinney, Donna M. Crabtree, Daniel T. Laskowitz, Marty G. Woldorff, et al. “The MARBLE Study Protocol: Modulating ApoE Signaling to Reduce Brain Inflammation, DeLirium, and PostopErative Cognitive Dysfunction.” J Alzheimers Dis 75, no. 4 (2020): 1319–28. https://doi.org/10.3233/JAD-191185.
       Full Text  Open Access Copy  Link to Item
    • Sze, Christina, Efrat Tsivian, Kae Jack Tay, Ariel A. Schulman, Leah G. Davis, Rajan T. Gupta, and Thomas J. Polascik. “Anterior gland focal cryoablation: proof-of-concept primary prostate cancer treatment in select men with localized anterior cancers detected by multi-parametric magnetic resonance imaging.” Bmc Urol 19, no. 1 (December 5, 2019): 127. https://doi.org/10.1186/s12894-019-0562-5.
       Full Text  Link to Item
    • Polascik, Thomas J. “Editorial Comment.” J Urol 202, no. 6 (December 2019): 1164–65. https://doi.org/10.1097/01.JU.0000581800.01651.5c.
       Full Text  Link to Item
    • Gross, Michael D., Art Sedrakyan, Fernando J. Bianco, Peter R. Carroll, Timothy J. Daskivich, Scott E. Eggener, Behfar Ehdaie, et al. “Reply by Authors.” J Urol 202, no. 5 (November 2019): 958. https://doi.org/10.1097/01.JU.0000579312.61159.39.
       Full Text  Link to Item
    • Gross, Michael D., Art Sedrakyan, Fernando J. Bianco, Peter R. Carroll, Timothy J. Daskivich, Scott E. Eggener, Behfar Ehdaie, et al. “SPARED Collaboration: Patient Selection for Partial Gland Ablation in Men with Localized Prostate Cancer.” J Urol 202, no. 5 (November 2019): 952–58. https://doi.org/10.1097/JU.0000000000000357.
       Full Text  Link to Item
    • Polascik, Thomas J., and Hazem Orabi. “Considerations of germline testing in prostate cancer screening.” Can J Urol 26, no. 5 Suppl 2 (October 2019): 46–47.
       Link to Item
    • Tay, Kae Jack, Thomas J. Polascik, Lauren E. Howard, Joseph K. Salama, Ariel A. Schulman, Zinan Chen, Christopher L. Amling, et al. “Salvage Radiotherapy for Recurrent Prostate Cancer: Can the Prognostic Grade Group System Inform Treatment Timing?” Clin Genitourin Cancer 17, no. 5 (October 2019): e930–38. https://doi.org/10.1016/j.clgc.2019.05.007.
       Full Text  Link to Item
    • Luijtelaar, A. van, B. M. Greenwood, H. U. Ahmed, A. B. Barqawi, E. Barret, J. G. R. Bomers, M. A. Brausi, et al. “Focal laser ablation as clinical treatment of prostate cancer: report from a Delphi consensus project.” World J Urol 37, no. 10 (October 2019): 2147–53. https://doi.org/10.1007/s00345-019-02636-7.
       Full Text  Link to Item
    • Aminsharifi, Alireza, Ariel Schulman, Lauren E. Howard, Kae Jack Tay, Christopher L. Amling, William J. Aronson, Matthew R. Cooperberg, et al. “Influence of African American race on the association between preoperative biopsy grade group and adverse histopathologic features of radical prostatectomy.” Cancer 125, no. 17 (September 1, 2019): 3025–32. https://doi.org/10.1002/cncr.32168.
       Full Text  Link to Item
    • Aminsharifi, Alireza, and Thomas J. Polascik. “Diagnosis and Management of Local Recurrence After Prostate Focal Therapy: Challenges and Solutions.” Eur Urol Oncol 2, no. 5 (September 2019): 539–40. https://doi.org/10.1016/j.euo.2019.07.008.
       Full Text  Link to Item
    • Aminsharifi, Alireza, Ross Simon, Thomas J. Polascik, Cary N. Robertson, Debra L. Sudan, Bradley H. Collins, and Judd W. Moul. “Evaluation and Active Treatment versus Active Surveillance of Localized Prostate Cancer in Renal Transplant Patients in the Era of Low and Very Low Risk Prostate Cancer.” J Urol 202, no. 3 (September 2019): 469–74. https://doi.org/10.1097/JU.0000000000000207.
       Full Text  Link to Item
    • Aminsharifi, Alireza, Ghalib Jibara, Efrat Tsivian, Matvey Tsivian, Ahmed Elshafei, and Thomas J. Polascik. “Salvage Prostate Cryoablation for the Management of Local Recurrence After Primary Cryotherapy: A Retrospective Analysis of Functional and Intermediate-Term Oncological Outcomes Associated With a Second Therapeutic Freeze.” Clin Genitourin Cancer 17, no. 4 (August 2019): e831–36. https://doi.org/10.1016/j.clgc.2019.05.014.
       Full Text  Link to Item
    • Berger, Miles, Deborah Oyeyemi, Mobolaji O. Olurinde, Heather E. Whitson, Kent J. Weinhold, Marty G. Woldorff, Lewis A. Lipsitz, et al. “The INTUIT Study: Investigating Neuroinflammation Underlying Postoperative Cognitive Dysfunction.” J Am Geriatr Soc 67, no. 4 (April 2019): 794–98. https://doi.org/10.1111/jgs.15770.
       Full Text  Open Access Copy  Link to Item
    • Tay, Kae Jack, Mahul B. Amin, Sangeet Ghai, Rafael E. Jimenez, James G. Kench, Laurence Klotz, Rodolfo Montironi, et al. “Surveillance after prostate focal therapy.” World J Urol 37, no. 3 (March 2019): 397–407. https://doi.org/10.1007/s00345-018-2363-y.
       Full Text  Link to Item
    • Tsivian, Efrat, Matvey Tsivian, Christina Sze, Ariel Schulman, and Thomas J. Polascik. “Clinicopathological characteristics of surgically treated localized renal masses in patients previously exposed to chemotherapy.” Int Braz J Urol 45, no. 2 (March 2019): 332–39. https://doi.org/10.1590/S1677-5538.IBJU.2018.0126.
       Full Text  Link to Item
    • Aminsharifi, Alireza, Lauren E. Howard, Christopher L. Amling, William J. Aronson, Matthew R. Cooperberg, Christopher J. Kane, Martha K. Terris, Thomas J. Polascik, and Stephen J. Freedland. “Statins are Associated With Increased Biochemical Recurrence After Radical Prostatectomy in Diabetic Men but no Association was Seen in Men also Taking Metformin: Results From the SEARCH Database.” Clin Genitourin Cancer 17, no. 1 (February 2019): e140–49. https://doi.org/10.1016/j.clgc.2018.09.020.
       Full Text  Link to Item
    • Aminsharifi, Alireza, Rajan T. Gupta, Efrat Tsivian, Sitharthan Sekar, Christina Sze, and Thomas J. Polascik. “Reduced Core Targeted (RCT) biopsy: Combining multiparametric magnetic resonance imaging - transrectal ultrasound fusion targeted biopsy with laterally-directed sextant biopsies - An alternative template for prostate fusion biopsy.” Eur J Radiol 110 (January 2019): 7–13. https://doi.org/10.1016/j.ejrad.2018.11.006.
       Full Text  Link to Item
    • Polascik, Thomas J. “The use of multiparametric MRI in diagnosis and active surveillance of prostate cancer.” Clin Adv Hematol Oncol 16, no. 12 (December 2018): 798–99.
       Link to Item
    • Aminsharifi, Alireza, Ariel Schulman, John Anderson, Laura Fish, Kevin Oeffinger, Kevin Shah, Christina Sze, Kae J. Tay, Efrat Tsivian, and Thomas J. Polascik. “Primary care perspective and implementation of a multidisciplinary, institutional prostate cancer screening algorithm embedded in the electronic health record.” Urol Oncol 36, no. 11 (November 2018): 502.e1-502.e6. https://doi.org/10.1016/j.urolonc.2018.07.016.
       Full Text  Link to Item
    • Aminsharifi, Alireza, Jean de la Rosette, and Thomas J. Polascik. “Focal therapy of prostate and kidney cancer.” Curr Opin Urol 28, no. 6 (November 2018): 491–92. https://doi.org/10.1097/MOU.0000000000000552.
       Full Text  Link to Item
    • Aminsharifi, Alireza, Rajan T. Gupta, Jiaoti Huang, and Thomas J. Polascik. “Three-dimensional localization and targeting of prostate cancer foci with imaging and histopathologic correlation: establishing a multidisciplinary team for quality improvement.” Curr Opin Urol 28, no. 6 (November 2018): 506–11. https://doi.org/10.1097/MOU.0000000000000554.
       Full Text  Link to Item
    • Sanchez-Salas, Rafael, Jean de la Rosette, Thomas J. Polascik, Arie Carneiro, Arjun Sivaraman, Xavier Cathelineau, and Jochen Walz. “Focal Therapy for Prostate Cancer: A More Vehement View of the Approach Could Translate into Real Benefits for Our Patients.” Eur Urol 74, no. 5 (November 2018): 537–39. https://doi.org/10.1016/j.eururo.2018.04.018.
       Full Text  Link to Item
    • Aminsharifi, Alireza, Lauren Howard, Yuan Wu, Amanda De Hoedt, Charlotte Bailey, Stephen J. Freedland, and Thomas J. Polascik. “Prostate Specific Antigen Density as a Predictor of Clinically Significant Prostate Cancer When the Prostate Specific Antigen is in the Diagnostic Gray Zone: Defining the Optimum Cutoff Point Stratified by Race and Body Mass Index.” J Urol 200, no. 4 (October 2018): 758–66. https://doi.org/10.1016/j.juro.2018.05.016.
       Full Text  Link to Item
    • Aminsharifi, Alireza, and Thomas J. Polascik. “Re: Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy with Brachytherapy Boost and Disease Progression and Mortality in Patients with Gleason Score 9-10 Prostate Cancer.” Eur Urol 74, no. 4 (October 2018): 526. https://doi.org/10.1016/j.eururo.2018.05.031.
       Full Text  Link to Item
    • Aminsharifi, Alireza, Thomas J. Polascik, Ariel Schulman, Kae Jack Tay, Ghalib Jibara, Christina Sze, Efrat Tsivian, Ahmed Elshafei, and J Stephen Jones. “Predictors of Rectourethral Fistula Formation After Primary Whole-Gland Cryoablation for Prostate Cancer: Results from the Cryo On-Line Database Registry.” J Endourol 32, no. 9 (September 12, 2018): 791–96. https://doi.org/10.1089/end.2018.0357.
       Full Text  Link to Item
    • Aminsharifi, Alireza, and Thomas J. Polascik. “Re: Prevalence and Prognosis of Low-volume, Oligorecurrent, Hormone-sensitive Prostate Cancer Amenable to Lesion Ablative Therapy.” Eur Urol 74, no. 2 (August 2018): 234–35. https://doi.org/10.1016/j.eururo.2018.01.022.
       Full Text  Link to Item
    • Duvnjak, Petar, Ariel A. Schulman, Jamie N. Holtz, Jiaoti Huang, Thomas J. Polascik, and Rajan T. Gupta. “Multiparametric Prostate MR Imaging: Impact on Clinical Staging and Decision Making.” Urol Clin North Am 45, no. 3 (August 2018): 455–66. https://doi.org/10.1016/j.ucl.2018.03.010.
       Full Text  Link to Item
    • Tsivian, Matvey, Michael R. Abern, Efrat Tsivian, Christina Sze, Ghalib Jibara, Edward N. Rampersaud, and Thomas J. Polascik. “Effect of blood transfusions on oncological outcomes of surgically treated localized renal cell carcinoma.” Urol Oncol 36, no. 8 (August 2018): 362.e1-362.e7. https://doi.org/10.1016/j.urolonc.2018.04.014.
       Full Text  Link to Item
    • Aminsharifi, Alireza, and Thomas J. Polascik. “Editorial Comment.” J Urol 199, no. 6 (June 2018): 1508–9. https://doi.org/10.1016/j.juro.2017.12.078.
       Full Text  Link to Item
    • Punnen, Sanoj, Stephen J. Freedland, Thomas J. Polascik, Stacy Loeb, Michael C. Risk, Stephen Savage, Sharad C. Mathur, Edward Uchio, Yan Dong, and Jonathan L. Silberstein. “A Multi-Institutional Prospective Trial Confirms Noninvasive Blood Test Maintains Predictive Value in African American Men.” J Urol 199, no. 6 (June 2018): 1459–63. https://doi.org/10.1016/j.juro.2017.11.113.
       Full Text  Link to Item
    • Elshafei, Ahmed, Kae Jack Tay, Onder Kara, Ercan Malkoc, Yaw Nyame, Hans Arora, Asmaa Hatem, et al. “Associations Between Prostate Volume and Oncologic Outcomes in Men Undergoing Focal Cryoablation of the Prostate.” Clin Genitourin Cancer 16, no. 2 (April 2018): e477–82. https://doi.org/10.1016/j.clgc.2017.10.009.
       Full Text  Link to Item
    • Duvnjak, Petar, Ariel A. Schulman, Jamie N. Holtz, Jiaoti Huang, Thomas J. Polascik, and Rajan T. Gupta. “Multiparametric Prostate MR Imaging: Impact on Clinical Staging and Decision Making.” Radiol Clin North Am 56, no. 2 (March 2018): 239–50. https://doi.org/10.1016/j.rcl.2017.10.007.
       Full Text  Link to Item
    • Holtz, Jamie N., Rachel Kloss Silverman, Kae Jack Tay, Jill T. Browning, Jiaoti Huang, Thomas J. Polascik, and Rajan T. Gupta. “New prostate cancer prognostic grade group (PGG): Can multiparametric MRI (mpMRI) accurately separate patients with low-, intermediate-, and high-grade cancer?” Abdom Radiol (Ny) 43, no. 3 (March 2018): 702–12. https://doi.org/10.1007/s00261-017-1255-8.
       Full Text  Link to Item
    • Baust, John M., Yoed Rabin, Thomas J. Polascik, Kimberly L. Santucci, Kristi K. Snyder, Robert G. Van Buskirk, and John G. Baust. “Defeating Cancers' Adaptive Defensive Strategies Using Thermal Therapies: Examining Cancer's Therapeutic Resistance, Ablative, and Computational Modeling Strategies as a means for Improving Therapeutic Outcome.” Technol Cancer Res Treat 17 (January 1, 2018): 1533033818762207. https://doi.org/10.1177/1533033818762207.
       Full Text  Link to Item
    • Patel, Malhar P., Ariel Schulman, Kevin P. Shah, John B. Anderson, and Thomas J. Polascik. “Engaging the primary care community to encourage appropriate prostate cancer screening.” Ther Adv Urol 10, no. 1 (January 2018): 11–16. https://doi.org/10.1177/1756287217735799.
       Full Text  Link to Item
    • Schulman, Ariel A., Lauren E. Howard, Kae Jack Tay, Efrat Tsivian, Christina Sze, Christopher L. Amling, William J. Aronson, et al. “Validation of the 2015 prostate cancer grade groups for predicting long-term oncologic outcomes in a shared equal-access health system.” Cancer 123, no. 21 (November 1, 2017): 4122–29. https://doi.org/10.1002/cncr.30844.
       Full Text  Link to Item
    • Tay, K. J., M. J. Scheltema, H. U. Ahmed, E. Barret, J. A. Coleman, J. Dominguez-Escrig, S. Ghai, et al. “Patient selection for prostate focal therapy in the era of active surveillance: an International Delphi Consensus Project.” Prostate Cancer Prostatic Dis 20, no. 3 (September 2017): 294–99. https://doi.org/10.1038/pcan.2017.8.
       Full Text  Link to Item
    • Tay, K. J., R. T. Gupta, J. Holtz, R. K. Silverman, E. Tsivian, A. Schulman, J. W. Moul, and T. J. Polascik. “Does mpMRI improve clinical criteria in selecting men with prostate cancer for active surveillance?” Prostate Cancer Prostatic Dis 20, no. 3 (September 2017): 323–27. https://doi.org/10.1038/pcan.2017.20.
       Full Text  Link to Item
    • Tay, Kae Jack, Ariel A. Schulman, Christina Sze, Efrat Tsivian, and Thomas J. Polascik. “New advances in focal therapy for early stage prostate cancer.” Expert Rev Anticancer Ther 17, no. 8 (August 2017): 737–43. https://doi.org/10.1080/14737140.2017.1345630.
       Full Text  Link to Item
    • Schulman, Ariel A., Christina Sze, Efrat Tsivian, Rajan T. Gupta, Judd W. Moul, and Thomas J. Polascik. “The Contemporary Role of Multiparametric Magnetic Resonance Imaging in Active Surveillance for Prostate Cancer.” Curr Urol Rep 18, no. 7 (July 2017): 52. https://doi.org/10.1007/s11934-017-0699-2.
       Full Text  Link to Item
    • Schulman, Ariel A., and Thomas J. Polascik. “Most of patients with localized prostate cancer will be treated in the future? | Opinion: No.” Int Braz J Urol 43, no. 4 (July 2017): 584–87. https://doi.org/10.1590/S1677-5538.IBJU.2017.04.03.
       Full Text  Link to Item
    • Tsivian, Efrat, Matvey Tsivian, Kae Jack Tay, Thomas Longo, Ziv Zukerman, Giuseppe Martorana, Riccardo Schiavina, Eugenio Brunocilla, and Thomas J. Polascik. “Body mass index and the clinicopathological characteristics of clinically localized renal masses-An international retrospective review.” Urol Oncol 35, no. 7 (July 2017): 459.e1-459.e5. https://doi.org/10.1016/j.urolonc.2017.02.004.
       Full Text  Link to Item
    • Tay, Kae Jack, Thomas James Polascik, Ahmed Elshafei, Efrat Tsivian, and J Stephen Jones. “Propensity Score-Matched Comparison of Partial to Whole-Gland Cryotherapy for Intermediate-Risk Prostate Cancer: An Analysis of the Cryo On-Line Data Registry Data.” J Endourol 31, no. 6 (June 2017): 564–71. https://doi.org/10.1089/end.2016.0830.
       Full Text  Link to Item
    • Nyame, Yaw A., Ahmed Elshafei, Daniel J. Greene, Hans C. Arora, Robert W. Given, Kae Jack Tay, Thomas J. Polascik, et al. “Prostate Specific Antigen Nadir of 0.1 or Less Is a Predictor of Treatment Success in Men Undergoing Salvage Whole Prostate Gland Cryoablation.” J Endourol 31, no. 5 (May 2017): 497–501. https://doi.org/10.1089/end.2016.0715.
       Full Text  Link to Item
    • Scheltema, M. J., K. J. Tay, A. W. Postema, D. M. de Bruin, J. Feller, J. J. Futterer, A. K. George, et al. “Utilization of multiparametric prostate magnetic resonance imaging in clinical practice and focal therapy: report from a Delphi consensus project.” World J Urol 35, no. 5 (May 2017): 695–701. https://doi.org/10.1007/s00345-016-1932-1.
       Full Text  Link to Item
    • Schulman, Ariel A., Kae Jack Tay, Cary N. Robertson, and Thomas J. Polascik. “High-intensity focused ultrasound for focal therapy: reality or pitfall?” Curr Opin Urol 27, no. 2 (March 2017): 138–48. https://doi.org/10.1097/MOU.0000000000000372.
       Full Text  Link to Item
    • Schulman, Ariel A., Kae Jack Tay, and Thomas J. Polascik. “Expanding thermal ablation to the 'intermediate-sized' renal mass: clinical utility in T1b tumors.” Transl Androl Urol 6, no. 1 (February 2017): 127–30. https://doi.org/10.21037/tau.2017.01.08.
       Full Text  Link to Item
    • Tsivian, Matvey, Rajan T. Gupta, Efrat Tsivian, Peter Qi, Melissa H. Mendez, Michael R. Abern, Kae Jack Tay, and Thomas J. Polascik. “Assessing clinically significant prostate cancer: Diagnostic properties of multiparametric magnetic resonance imaging compared to three-dimensional transperineal template mapping histopathology.” Int J Urol 24, no. 2 (February 2017): 137–43. https://doi.org/10.1111/iju.13251.
       Full Text  Link to Item
    • Valerio, Massimo, Yannick Cerantola, Scott E. Eggener, Herbert Lepor, Thomas J. Polascik, Arnauld Villers, and Mark Emberton. “New and Established Technology in Focal Ablation of the Prostate: A Systematic Review.” Eur Urol 71, no. 1 (January 2017): 17–34. https://doi.org/10.1016/j.eururo.2016.08.044.
       Full Text  Link to Item
    • Holtz, Jamie N., Kae Jack Tay, Thomas J. Polascik, and Rajan T. Gupta. “Integration of multiparametric MRI into active surveillance of prostate cancer.” Future Oncol 12, no. 21 (November 2016): 2513–29. https://doi.org/10.2217/fon-2016-0142.
       Full Text  Link to Item
    • Tay, Kae Jack, Arnauld Villers, and Thomas J. Polascik. “Targeted Anterior Gland Focal Therapy-a Novel Treatment Option for a Better Defined Disease.” Curr Urol Rep 17, no. 10 (October 2016): 69. https://doi.org/10.1007/s11934-016-0628-9.
       Full Text  Link to Item
    • Postema, A. W., T. M. De Reijke, O. Ukimura, W. Van den Bos, A. R. Azzouzi, E. Barret, D. Baumunk, et al. “Standardization of definitions in focal therapy of prostate cancer: report from a Delphi consensus project.” World J Urol 34, no. 10 (October 2016): 1373–82. https://doi.org/10.1007/s00345-016-1782-x.
       Full Text  Link to Item
    • Ehieli, Eric I., Lauren E. Howard, Terri G. Monk, Michael N. Ferrandino, Thomas J. Polascik, Philip J. Walther, and Stephen J. Freedland. “Effect of positive end-expiratory pressure on blood loss during retropubic and robot-assisted laparoscopic radical prostatectomy.” Int J Urol 23, no. 8 (August 2016): 674–78. https://doi.org/10.1111/iju.13125.
       Full Text  Link to Item
    • Tay, Kae Jack, Rajan T. Gupta, Alison F. Brown, Rachel K. Silverman, and Thomas J. Polascik. “Defining the Incremental Utility of Prostate Multiparametric Magnetic Resonance Imaging at Standard and Specialized Read in Predicting Extracapsular Extension of Prostate Cancer.” Eur Urol 70, no. 2 (August 2016): 211–13. https://doi.org/10.1016/j.eururo.2015.10.041.
       Full Text  Link to Item
    • Gupta, Rajan T., Alison Flanagan Brown, Rachel Kloss Silverman, Kae Jack Tay, John F. Madden, Daniel J. George, and Thomas J. Polascik. “Can Radiologic Staging With Multiparametric MRI Enhance the Accuracy of the Partin Tables in Predicting Organ-Confined Prostate Cancer?” Ajr Am J Roentgenol 207, no. 1 (July 2016): 87–95. https://doi.org/10.2214/AJR.15.15878.
       Full Text  Link to Item
    • Tay, K. J., and T. J. Polascik. “Focal Cryotherapy for Localized Prostate Cancer.” Arch Esp Urol 69, no. 6 (July 2016): 317–26.
       Link to Item
    • Kovac, Evan, Ahmed ElShafei, Kae Jack Tay, Melissa Mendez, Thomas J. Polascik, and J Stephen Jones. “Five-Year Biochemical Progression-Free Survival Following Salvage Whole-Gland Prostate Cryoablation: Defining Success with Nadir Prostate-Specific Antigen.” J Endourol 30, no. 6 (June 2016): 624–31. https://doi.org/10.1089/end.2015.0719.
       Full Text  Link to Item
    • Palmeri, Mark L., Tyler J. Glass, Zachary A. Miller, Stephen J. Rosenzweig, Andrew Buck, Thomas J. Polascik, Rajan T. Gupta, Alison F. Brown, John Madden, and Kathryn R. Nightingale. “Identifying Clinically Significant Prostate Cancers using 3-D In Vivo Acoustic Radiation Force Impulse Imaging with Whole-Mount Histology Validation.” Ultrasound Med Biol 42, no. 6 (June 2016): 1251–62. https://doi.org/10.1016/j.ultrasmedbio.2016.01.004.
       Full Text  Link to Item
    • Tay, Kae Jack, Rajan T. Gupta, Ardeshir R. Rastinehad, Efrat Tsivian, Stephen J. Freedland, Judd W. Moul, and Thomas J. Polascik. “Navigating MRI-TRUS fusion biopsy: optimizing the process and avoiding technical pitfalls.” Expert Rev Anticancer Ther 16, no. 3 (2016): 303–11. https://doi.org/10.1586/14737140.2016.1131155.
       Full Text  Link to Item
    • Tay, Kae Jack, Thomas J. Polascik, Ahmed Elshafei, Michael L. Cher, Robert W. Given, Vladimir Mouraviev, Ashley E. Ross, and J Stephen Jones. “Primary Cryotherapy for High-Grade Clinically Localized Prostate Cancer: Oncologic and Functional Outcomes from the COLD Registry.” J Endourol 30, no. 1 (January 2016): 43–48. https://doi.org/10.1089/end.2015.0403.
       Full Text  Link to Item
    • Zargar, Homayoun, Thomas D. Atwell, Jeffrey A. Cadeddu, Jean J. de la Rosette, Gunther Janetschek, Jihad H. Kaouk, Surena F. Matin, Thomas J. Polascik, Kamran Zargar-Shoshtari, and R Houston Thompson. “Cryoablation for Small Renal Masses: Selection Criteria, Complications, and Functional and Oncologic Results.” Eur Urol 69, no. 1 (January 2016): 116–28. https://doi.org/10.1016/j.eururo.2015.03.027.
       Full Text  Link to Item
    • Mendez, Melissa H., Niccolo Maria Passoni, Julio Pow-Sang, J Stephen Jones, and Thomas J. Polascik. “Comparison of Outcomes Between Preoperatively Potent Men Treated with Focal Versus Whole Gland Cryotherapy in a Matched Population.” J Endourol 29, no. 10 (October 2015): 1193–98. https://doi.org/10.1089/end.2014.0881.
       Full Text  Link to Item
    • Muller, B. G., W. van den Bos, M. Brausi, J. J. Fütterer, S. Ghai, P. A. Pinto, I. V. Popeneciu, et al. “Follow-up modalities in focal therapy for prostate cancer: results from a Delphi consensus project.” World J Urol 33, no. 10 (October 2015): 1503–9. https://doi.org/10.1007/s00345-014-1475-2.
       Full Text  Link to Item
    • Elshafei, Ahmed, Evan Kovac, Nivedita Dhar, David Levy, Thomas Polascik, Vladimir Mouraviev, Changhong Yu, and J Stephen Jones. “A pretreatment nomogram for prediction of biochemical failure after primary cryoablation of the prostate.” Prostate 75, no. 13 (September 2015): 1447–53. https://doi.org/10.1002/pros.23030.
       Full Text  Link to Item
    • Gupta, Rajan T., Christopher R. Kauffman, Kirema Garcia-Reyes, Mark L. Palmeri, John F. Madden, Thomas J. Polascik, and Andrew B. Rosenkrantz. “Apparent Diffusion Coefficient Values of the Benign Central Zone of the Prostate: Comparison With Low- and High-Grade Prostate Cancer.” Ajr Am J Roentgenol 205, no. 2 (August 2015): 331–36. https://doi.org/10.2214/AJR.14.14221.
       Full Text  Link to Item
    • Baust, J. G., J. C. Bischof, S. Jiang-Hughes, T. J. Polascik, D. B. Rukstalis, A. A. Gage, and J. M. Baust. “Re-purposing cryoablation: a combinatorial 'therapy' for the destruction of tissue.” Prostate Cancer Prostatic Dis 18, no. 2 (June 2015): 87–95. https://doi.org/10.1038/pcan.2014.54.
       Full Text  Link to Item
    • Mendez, Melissa H., Daniel Y. Joh, Rajan Gupta, and Thomas J. Polascik. “Current trends and new frontiers in focal therapy for localized prostate cancer.” Curr Urol Rep 16, no. 6 (June 2015): 35. https://doi.org/10.1007/s11934-015-0513-y.
       Full Text  Link to Item
    • Tay, Kae Jack, Melissa Mendez, Judd W. Moul, and Thomas J. Polascik. “Active surveillance for prostate cancer: can we modernize contemporary protocols to improve patient selection and outcomes in the focal therapy era?” Curr Opin Urol 25, no. 3 (May 2015): 185–90. https://doi.org/10.1097/MOU.0000000000000168.
       Full Text  Link to Item
    • Azrad, M., R. T. Vollmer, J. Madden, T. J. Polascik, D. C. Snyder, M. T. Ruffin, J. W. Moul, D. Brenner, X. He, and W. Demark-Wahnefried. “Disparate results between proliferation rates of surgically excised prostate tumors and an in vitro bioassay using sera from a positive randomized controlled trial.” Biotech Histochem 90, no. 3 (April 2015): 184–89. https://doi.org/10.3109/10520295.2014.976840.
       Full Text  Link to Item
    • Donaldson, Ian A., Roberto Alonzi, Dean Barratt, Eric Barret, Viktor Berge, Simon Bott, David Bottomley, et al. “Focal therapy: patients, interventions, and outcomes--a report from a consensus meeting.” Eur Urol 67, no. 4 (April 2015): 771–77. https://doi.org/10.1016/j.eururo.2014.09.018.
       Full Text  Link to Item
    • Garcia-Reyes, Kirema, Niccolò M. Passoni, Mark L. Palmeri, Christopher R. Kauffman, Kingshuk Roy Choudhury, Thomas J. Polascik, and Rajan T. Gupta. “Detection of prostate cancer with multiparametric MRI (mpMRI): effect of dedicated reader education on accuracy and confidence of index and anterior cancer diagnosis.” Abdom Imaging 40, no. 1 (January 2015): 134–42. https://doi.org/10.1007/s00261-014-0197-7.
       Full Text  Link to Item
    • Palmeri, Mark L., Zachary A. Miller, Tyler J. Glass, Kirema Garcia-Reyes, Rajan T. Gupta, Stephen J. Rosenzweig, Christopher Kauffman, et al. “B-mode and acoustic radiation force impulse (ARFI) imaging of prostate zonal anatomy: comparison with 3T T2-weighted MR imaging.” Ultrason Imaging 37, no. 1 (January 2015): 22–41. https://doi.org/10.1177/0161734614542177.
       Full Text  Link to Item
    • Polascik, Thomas J., Niccolo’ M. Passoni, Arnauld Villers, and Peter L. Choyke. “Modernizing the diagnostic and decision-making pathway for prostate cancer.” Clin Cancer Res 20, no. 24 (December 15, 2014): 6254–57. https://doi.org/10.1158/1078-0432.CCR-14-0247.
       Full Text  Link to Item
    • Gupta, R. T., T. J. Polascik, S. S. Taneja, and A. B. Rosenkrantz. “Recent Developments in Multiparametric Prostate MR Imaging.” Current Radiology Reports 2, no. 12 (December 14, 2014). https://doi.org/10.1007/s40134-014-0074-8.
       Full Text
    • Stewart, Suzanne B., Judd W. Moul, Thomas J. Polascik, Bridget F. Koontz, Cary N. Robertson, Stephen J. Freedland, Daniel J. George, W Robert Lee, Andrew J. Armstrong, and Lionel L. Bañez. “Does the multidisciplinary approach improve oncological outcomes in men undergoing surgical treatment for prostate cancer?” Int J Urol 21, no. 12 (December 2014): 1215–19. https://doi.org/10.1111/iju.12561.
       Full Text  Link to Item
    • Gupta, Rajan T., Kamil F. Faridi, Abhay A. Singh, Niccolò M. Passoni, Kirema Garcia-Reyes, John F. Madden, and Thomas J. Polascik. “Comparing 3-T multiparametric MRI and the Partin tables to predict organ-confined prostate cancer after radical prostatectomy.” Urol Oncol 32, no. 8 (November 2014): 1292–99. https://doi.org/10.1016/j.urolonc.2014.04.017.
       Full Text  Link to Item
    • Klotz, Laurence, and Thomas J. Polascik. “Low-risk and very-low-risk prostate cancer: is there a role for focal therapy in the era of active surveillance? Yes, the two approaches complement each other.” Oncology (Williston Park) 28, no. 11 (November 2014): 950-9C3.
       Link to Item
    • Muller, Berrend G., Willemien van den Bos, Maurizio Brausi, Francois Cornud, Paolo Gontero, Alexander Kirkham, Peter A. Pinto, et al. “Role of multiparametric magnetic resonance imaging (MRI) in focal therapy for prostate cancer: a Delphi consensus project.” Bju Int 114, no. 5 (November 2014): 698–707. https://doi.org/10.1111/bju.12548.
       Full Text  Link to Item
    • Bailey, Donald E., Meredith Wallace Kazer, Thomas J. Polascik, and Cary Robertson. “Psychosocial trajectories of men monitoring prostate-specific antigen levels following surgery for prostate cancer.” Oncol Nurs Forum 41, no. 4 (July 1, 2014): 361–68. https://doi.org/10.1188/14.ONF.361-368.
       Full Text  Link to Item
    • Tsivian, Matvey, Edward N. Rampersaud, Maria del Pilar Laguna Pes, Steven Joniau, Raymond J. Leveillee, William B. Shingleton, Monish Aron, et al. “Small renal mass biopsy--how, what and when: report from an international consensus panel.” Bju Int 113, no. 6 (June 2014): 854–63. https://doi.org/10.1111/bju.12470.
       Full Text  Link to Item
    • Abern, Michael R., Emelian Scosyrev, Matvey Tsivian, Edward M. Messing, Thomas J. Polascik, and Arkadiusz Z. Dudek. “Survival of patients undergoing cytoreductive surgery for metastatic renal cell carcinoma in the targeted-therapy era.” Anticancer Res 34, no. 5 (May 2014): 2405–11.
       Link to Item
    • Habib, Ashraf S., Judd W. Moul, Thomas J. Polascik, Cary N. Robertson, Anthony M. Roche, William D. White, Stephen E. Hill, Israel Nosnick, Tong J. Gan, and Tong J. Duke Perioperative Outcome Study Group. “Low central venous pressure versus acute normovolemic hemodilution versus conventional fluid management for reducing blood loss in radical retropubic prostatectomy: a randomized controlled trial.” Curr Med Res Opin 30, no. 5 (May 2014): 937–43. https://doi.org/10.1185/03007995.2013.877436.
       Full Text  Link to Item
    • Tsivian, Matvey, Michael R. Abern, John J. Yoo, Paul Evans, Peter Qi, Charles Y. Kim, Michael E. Lipkin, Thomas J. Polascik, and Michael N. Ferrandino. “Radiation exposure associated with dedicated renal mass computed tomography protocol: impact of patient characteristics.” J Endourol 27, no. 9 (September 2013): 1102–6. https://doi.org/10.1089/end.2013.0111.
       Full Text  Link to Item
    • Tsivian, Matvey, and Thomas J. Polascik. “Bilateral focal ablation of prostate tissue using low-energy direct current (LEDC): a preclinical canine study.” Bju Int 112, no. 4 (August 2013): 526–30. https://doi.org/10.1111/bju.12227.
       Full Text  Link to Item
    • Abern, Michael R., Matvey Tsivian, and Thomas J. Polascik. “Refining treatment for the men who need it: lessons from the PIVOT trial.” Transl Androl Urol 2, no. 2 (June 2013): 82–84. https://doi.org/10.3978/j.issn.2223-4683.2012.09.05.
       Full Text  Link to Item
    • Azrad, Maria, Robin T. Vollmer, John Madden, Mark Dewhirst, Thomas J. Polascik, Denise C. Snyder, Mack T. Ruffin, Judd W. Moul, Dean E. Brenner, and Wendy Demark-Wahnefried. “Flaxseed-derived enterolactone is inversely associated with tumor cell proliferation in men with localized prostate cancer.” J Med Food 16, no. 4 (April 2013): 357–60. https://doi.org/10.1089/jmf.2012.0159.
       Full Text  Link to Item
    • Gupta, Rajan T., Christopher R. Kauffman, Thomas J. Polascik, Samir S. Taneja, and Andrew B. Rosenkrantz. “The state of prostate MRI in 2013.” Oncology (Williston Park) 27, no. 4 (April 2013): 262–70.
       Link to Item
    • Fu, Qiang, Judd W. Moul, Lionel Bañez, Leon Sun, Vladimir Mouraviev, Donghua Xie, and Thomas J. Polascik. “Preoperative predictors of pathologic stage T2a and pathologic Gleason score ≤ 6 in men with clinical low-risk prostate cancer treated with radical prostatectomy: reference for active surveillance.” Med Oncol 30, no. 1 (March 2013): 326. https://doi.org/10.1007/s12032-012-0326-5.
       Full Text  Link to Item
    • Kimura, M., L. L. Bañez, T. J. Polascik, R. M. Bernal, L. Gerber, C. N. Robertson, C. F. Donatucci, and J. W. Moul. “Sexual bother and function after radical prostatectomy: predictors of sexual bother recovery in men despite persistent post-operative sexual dysfunction.” Andrology 1, no. 2 (March 2013): 256–61. https://doi.org/10.1111/j.2047-2927.2012.00036.x.
       Full Text  Link to Item
    • Fu, Q., J. W. Moul, L. Bañez, L. Sun, V. Mouraviev, D. Xie, and T. J. Polascik. “Preoperative predictors of pathologic stage T2a and pathologic Gleason score ≤ 6 in men with clinical low-risk prostate cancer treated with radical prostatectomy: reference for active surveillance.” Medical Oncology (Northwood, London, England) 30, no. 1 (2013): 326–326.
    • Tsivian, M., M. R. Abern, and T. J. Polascik. “Evolution of the concept of focal therapy for prostate cancer.” Oncology (Williston Park, N.Y.) 27, no. 1 (January 1, 2013).
    • Tsivian, Matvey, Michael R. Abern, and Thomas J. Polascik. “Evolution of the concept of focal therapy for prostate cancer.” Oncology (Williston Park) 27, no. 1 (January 2013): 64–70.
       Link to Item
    • Mouraviev, Vladimir, Talaignair N. Venkatraman, Artak Tovmasyan, Masaki Kimura, Matvey Tsivian, Vladimira Mouravieva, Tom J. Polascik, et al. “Mn porphyrins as novel molecular magnetic resonance imaging contrast agents.” J Endourol 26, no. 11 (November 2012): 1420–24. https://doi.org/10.1089/end.2012.0171.
       Full Text  Link to Item
    • Mues, Adam C., Ruslan Korets, Joseph A. Graversen, Ketan K. Badani, Vincent G. Bird, Sara L. Best, Jeffrey A. Cadeddu, et al. “Clinical, pathologic, and functional outcomes after nephron-sparing surgery in patients with a solitary kidney: a multicenter experience.” J Endourol 26, no. 10 (October 2012): 1361–66. https://doi.org/10.1089/end.2012.0114.
       Full Text  Link to Item
    • Smeenge, Martijn, Jelle Barentsz, David Cosgrove, Jean de la Rosette, Theo de Reijke, Scott Eggener, Ferdinand Frauscher, et al. “Role of transrectal ultrasonography (TRUS) in focal therapy of prostate cancer: report from a Consensus Panel.” Bju Int 110, no. 7 (October 2012): 942–48. https://doi.org/10.1111/j.1464-410X.2012.11072.x.
       Full Text  Link to Item
    • Volpe, Alessandro, Antonio Finelli, Inderbir S. Gill, Michael A. S. Jewett, Guido Martignoni, Thomas J. Polascik, Mesut Remzi, and Robert G. Uzzo. “Rationale for percutaneous biopsy and histologic characterisation of renal tumours.” Eur Urol 62, no. 3 (September 2012): 491–504. https://doi.org/10.1016/j.eururo.2012.05.009.
       Full Text  Link to Item
    • Caso, Jorge R., Matvey Tsivian, Vladimir Mouraviev, and Thomas J. Polascik. “Predicting biopsy-proven prostate cancer recurrence following cryosurgery.” Urol Oncol 30, no. 4 (July 2012): 391–95. https://doi.org/10.1016/j.urolonc.2010.04.001.
       Full Text  Link to Item
    • Abern, Michael R., Matvey Tsivian, Thomas J. Polascik, and Christopher L. Coogan. “Characteristics and outcomes of tumors arising from the distal nephron.” Urology 80, no. 1 (July 2012): 140–46. https://doi.org/10.1016/j.urology.2012.03.034.
       Full Text  Link to Item
    • Ahmed, Hashim U., Oguz Akin, Jonathan A. Coleman, Sarah Crane, Mark Emberton, Larry Goldenberg, Hedvig Hricak, et al. “Transatlantic Consensus Group on active surveillance and focal therapy for prostate cancer.” Bju Int 109, no. 11 (June 2012): 1636–47. https://doi.org/10.1111/j.1464-410X.2011.10633.x.
       Full Text  Link to Item
    • Kimura, Masaki, Zahid N. Rabbani, Andrew R. Zodda, Hui Yan, Isabel L. Jackson, Thomas J. Polascik, Craig F. Donatucci, Judd W. Moul, Zeljko Vujaskovic, and Bridget F. Koontz. “Role of oxidative stress in a rat model of radiation-induced erectile dysfunction.” J Sex Med 9, no. 6 (June 2012): 1535–49. https://doi.org/10.1111/j.1743-6109.2012.02716.x.
       Full Text  Link to Item
    • Abern, Michael R., Matvey Tsivian, and Thomas J. Polascik. “Focal therapy of prostate cancer: evidence-based analysis for modern selection criteria.” Curr Urol Rep 13, no. 2 (April 2012): 160–69. https://doi.org/10.1007/s11934-012-0241-5.
       Full Text  Link to Item
    • Kimura, Masaki, Lionel L. Bañez, Leah Gerber, Jim Qi, Matvey Tsivian, Stephen J. Freedland, Takefumi Satoh, Thomas J. Polascik, Shiro Baba, and Judd W. Moul. “Association between preoperative erectile dysfunction and prostate cancer features--an analysis from the Duke Prostate Center Database.” J Sex Med 9, no. 4 (April 2012): 1174–81. https://doi.org/10.1111/j.1743-6109.2011.02547.x.
       Full Text  Link to Item
    • Tsivian, Matvey, Charles Y. Kim, Jorge R. Caso, Michael D. Rosenberg, Rendon C. Nelson, and Thomas J. Polascik. “Contrast enhancement on computed tomography after renal cryoablation: an evidence of treatment failure?” J Endourol 26, no. 4 (April 2012): 330–35. https://doi.org/10.1089/end.2011.0337.
       Full Text  Link to Item
    • Wattson, Daniel A., Ming-Hui Chen, Brian J. Moran, Daniel E. Dosoretz, Michelle H. Braccioforte, Sharon A. Salenius, and Anthony V. D’Amico. “The number of high-risk factors and the risk of prostate cancer-specific mortality after brachytherapy: implications for treatment selection.” Int J Radiat Oncol Biol Phys 82, no. 5 (April 1, 2012): e773–79. https://doi.org/10.1016/j.ijrobp.2011.11.023.
       Full Text  Link to Item
    • Baust, John M., Daniel P. Klossner, Anthony Robilotto, Robert G. Vanbuskirk, Andrew A. Gage, Vladimir Mouraviev, Thomas J. Polascik, and John G. Baust. “Vitamin D(3) cryosensitization increases prostate cancer susceptibility to cryoablation via mitochondrial-mediated apoptosis and necrosis.” Bju Int 109, no. 6 (March 2012): 949–58. https://doi.org/10.1111/j.1464-410X.2011.10408.x.
       Full Text  Link to Item
    • Caso, Jorge R., Matvey Tsivian, Vladimir Mouraviev, Masaki Kimura, and Thomas J. Polascik. “Complications and postoperative events after cryosurgery for prostate cancer.” Bju Int 109, no. 6 (March 2012): 840–45. https://doi.org/10.1111/j.1464-410X.2011.10423.x.
       Full Text  Link to Item
    • Tsivian, Matvey, Tiera Wright, Marva Price, Vladimir Mouraviev, John F. Madden, Masaki Kimura, Terrence Wong, and Thomas J. Polascik. “111-In-capromab pendetide imaging using hybrid-γ camera-computer tomography technology is not reliable in detecting seminal vesicle invasion in patients with prostate cancer.” Urol Oncol 30, no. 2 (March 2012): 150–54. https://doi.org/10.1016/j.urolonc.2009.12.005.
       Full Text  Link to Item
    • Fu, Qiang, Judd W. Moul, Lionel L. Bañez, Leon Sun, Vladimir Mouraviev, Donghua Xie, and Thomas J. Polascik. “Preoperative predictors of pathologic stage T2a in low-risk prostate cancer: implications for focal therapy.” Urol Int 89, no. 3 (2012): 296–300. https://doi.org/10.1159/000341556.
       Full Text  Link to Item
    • Stewart, Suzanne Biehn, Lionel L. Bañez, Cary N. Robertson, Stephen J. Freedland, Thomas J. Polascik, Donghua Xie, Bridget F. Koontz, et al. “Utilization trends at a multidisciplinary prostate cancer clinic: initial 5-year experience from the Duke Prostate Center.” J Urol 187, no. 1 (January 2012): 103–8. https://doi.org/10.1016/j.juro.2011.09.040.
       Full Text  Link to Item
    • Tsivian, Matvey, Peter Qi, Masaki Kimura, Valerie H. Chen, Stephanie H. Chen, Tong J. Gan, and Thomas J. Polascik. “The effect of noise-cancelling headphones or music on pain perception and anxiety in men undergoing transrectal prostate biopsy.” Urology 79, no. 1 (January 2012): 32–36. https://doi.org/10.1016/j.urology.2011.09.037.
       Full Text  Link to Item
    • Zhai, Liang, Thomas J. Polascik, Wen-Chi Foo, Stephen Rosenzweig, Mark L. Palmeri, John Madden, and Kathryn R. Nightingale. “Acoustic radiation force impulse imaging of human prostates: initial in vivo demonstration.” Ultrasound Med Biol 38, no. 1 (January 2012): 50–61. https://doi.org/10.1016/j.ultrasmedbio.2011.10.002.
       Full Text  Link to Item
    • Azrad, Maria, Kui Zhang, Robin T. Vollmer, John Madden, Thomas J. Polascik, Denise C. Snyder, Mack T. Ruffin, et al. “Prostatic alpha-linolenic acid (ALA) is positively associated with aggressive prostate cancer: a relationship which may depend on genetic variation in ALA metabolism.” Plos One 7, no. 12 (2012): e53104. https://doi.org/10.1371/journal.pone.0053104.
       Full Text  Open Access Copy  Link to Item
    • Tsivian, Matvey, Daniel M. Moreira, Leon Sun, Vladimir Mouraviev, Masaki Kimura, Judd W. Moul, and Thomas J. Polascik. “Biopsy accuracy in identifying unilateral prostate cancer depends on prostate weight.” Urologic Oncology 30, no. 1 (January 2012): 21–25. https://doi.org/10.1016/j.urolonc.2009.11.001.
       Full Text
    • Mouraviev, Vladimir, Talaignair N. Venkatraman, Artak Tovmasyan, Masaki Kimura, Matvey Tsivian, Vladimira Mouravieva, Tom J. Polascik, et al. “Mn-porphyrins as novel molecular magnetic resonance imaging contrast agents.” J Endourol, November 3, 2011, 1420–24. https://doi.org/10.1089/end.2011.0133.
       Full Text  Link to Item
    • Heymach, John V., Terry J. Shackleford, Hai T. Tran, Suk-Young Yoo, Kim-Anh Do, Melanie Wergin, Pierre Saintigny, et al. “Effect of low-fat diets on plasma levels of NF-κB-regulated inflammatory cytokines and angiogenic factors in men with prostate cancer.” Cancer Prev Res (Phila) 4, no. 10 (October 2011): 1590–98. https://doi.org/10.1158/1940-6207.CAPR-10-0136.
       Full Text  Link to Item
    • Mouraviev, Vladimir, Arnauld Villers, David G. Bostwick, Thomas M. Wheeler, Rodolfo Montironi, and Thomas J. Polascik. “Understanding the pathological features of focality, grade and tumour volume of early-stage prostate cancer as a foundation for parenchyma-sparing prostate cancer therapies: active surveillance and focal targeted therapy.” Bju Int 108, no. 7 (October 2011): 1074–85. https://doi.org/10.1111/j.1464-410X.2010.10039.x.
       Full Text  Link to Item
    • Van Poppel, Hein, Frank Becker, Jeffrey A. Cadeddu, Inderbir S. Gill, Gunther Janetschek, Michael A. S. Jewett, M Pilar Laguna, et al. “Treatment of localised renal cell carcinoma.” Eur Urol 60, no. 4 (October 2011): 662–72. https://doi.org/10.1016/j.eururo.2011.06.040.
       Full Text  Link to Item
    • Kimura, Masaki, Lionel L. Bañez, Florian R. Schroeck, Leah Gerber, Jim Qi, Takefumi Satoh, Shiro Baba, et al. “Factors predicting early and late phase decline of sexual health-related quality of life following radical prostatectomy.” J Sex Med 8, no. 10 (October 2011): 2935–43. https://doi.org/10.1111/j.1743-6109.2011.02387.x.
       Full Text  Link to Item
    • Cotter, Shane E., Ming Hui Chen, Judd W. Moul, W Robert Lee, Bridget F. Koontz, Mitchell S. Anscher, Cary N. Robertson, Philip J. Walther, Thomas J. Polascik, and Anthony V. D’Amico. “Salvage radiation in men after prostate-specific antigen failure and the risk of death.” Cancer 117, no. 17 (September 1, 2011): 3925–32. https://doi.org/10.1002/cncr.25993.
       Full Text  Link to Item
    • Kimura, Masaki, Hui Yan, Zahid Rabbani, Takefumi Satoh, Shiro Baba, Fang-fang Yin, Thomas J. Polascik, Craig F. Donatucci, Zeljko Vujaskovic, and Bridget F. Koontz. “Radiation-induced erectile dysfunction using prostate-confined modern radiotherapy in a rat model.” J Sex Med 8, no. 8 (August 2011): 2215–26. https://doi.org/10.1111/j.1743-6109.2011.02351.x.
       Full Text  Link to Item
    • Tsivian, Matvey, Jorge Caso, Masaki Kimura, and Thomas J. Polascik. “Renal function outcomes after laparoscopic renal cryoablation.” J Endourol 25, no. 8 (August 2011): 1287–91. https://doi.org/10.1089/end.2011.0017.
       Full Text  Link to Item
    • Tang, Ping, Leon Sun, Matthew A. Uhlman, Cary N. Robertson, Thomas J. Polascik, and Judd W. Moul. “Prostate-specific antigen velocity based risk-adapted discontinuation of prostate cancer screening in elderly men.” Bju Int 108, no. 1 (July 2011): 44–48. https://doi.org/10.1111/j.1464-410X.2010.09812.x.
       Full Text  Link to Item
    • Santucci, K. L., K. K. Snyder, J. M. Baust, R. G. Van Buskirk, V. Mouraviev, T. J. Polascik, A. A. Gage, and J. G. Baust. “Use of 1,25α dihydroxyvitamin D3 as a cryosensitizing agent in a murine prostate cancer model.” Prostate Cancer Prostatic Dis 14, no. 2 (June 2011): 97–104. https://doi.org/10.1038/pcan.2010.52.
       Full Text  Link to Item
    • Tsivian, Matvey, Daniel M. Moreira, Jorge R. Caso, Vladimir Mouraviev, and Thomas J. Polascik. “Cigarette smoking is associated with advanced renal cell carcinoma.” J Clin Oncol 29, no. 15 (May 20, 2011): 2027–31. https://doi.org/10.1200/JCO.2010.30.9484.
       Full Text  Link to Item
    • Rosenberg, Michael D., Charles Y. Kim, Matvey Tsivian, Matthew N. Suberlak, David R. Sopko, Thomas J. Polascik, and Rendon C. Nelson. “Percutaneous cryoablation of renal lesions with radiographic ice ball involvement of the renal sinus: analysis of hemorrhagic and collecting system complications.” Ajr Am J Roentgenol 196, no. 4 (April 2011): 935–39. https://doi.org/10.2214/AJR.10.5182.
       Full Text  Link to Item
    • Kimura, M., C. F. Donatucci, M. Tsivian, J. R. Caso, D. M. Moreira, V. Mouraviev, T. Satoh, S. Baba, and T. J. Polascik. “On-demand use of erectile aids in men with preoperative erectile dysfunction treated by whole gland prostate cryoablation.” Int J Impot Res 23, no. 2 (March 2011): 49–55. https://doi.org/10.1038/ijir.2011.3.
       Full Text  Link to Item
    • Mayes, Janice M., Vladimir Mouraviev, Leon Sun, Matvey Tsivian, John F. Madden, and Thomas J. Polascik. “Can the conventional sextant prostate biopsy accurately predict unilateral prostate cancer in low-risk, localized, prostate cancer?” Urol Oncol 29, no. 2 (March 2011): 166–70. https://doi.org/10.1016/j.urolonc.2009.03.011.
       Full Text  Link to Item
    • Tsivian, Matvey, Vladimir Mouraviev, David M. Albala, Jorge R. Caso, Cary N. Robertson, John F. Madden, and Thomas J. Polascik. “Clinical predictors of renal mass pathological features.” Bju Int 107, no. 5 (March 2011): 735–40. https://doi.org/10.1111/j.1464-410X.2010.09629.x.
       Full Text  Link to Item
    • Mouraviev, Vladimir, and Thomas J. Polascik. “New Frontiers in Imaging and Focal Therapy: Highlights From the Third International Symposium on Focal Therapy and Imaging of Prostate and Kidney Cancer, February 24-27, 2010, Washington, DC.” Rev Urol 13, no. 2 (2011): 104–11.
       Link to Item
    • D’Amico, Anthony V., Ming-Hui Chen, Leon Sun, W Robert Lee, Vladimir Mouraviev, Cary N. Robertson, Philip J. Walther, Thomas J. Polascik, David M. Albala, and Judd W. Moul. “Adjuvant versus salvage radiation therapy for prostate cancer and the risk of death.” Bju Int 106, no. 11 (December 2010): 1618–22. https://doi.org/10.1111/j.1464-410X.2010.09447.x.
       Full Text  Link to Item
    • Caso, Jorge R., Matvey Tsivian, Vladimir Mouraviev, Thomas J. Polascik, and Judd W. Moul. “Pathological T2 sub-divisions as a prognostic factor in the biochemical recurrence of prostate cancer.” Bju International 106, no. 11 (December 2010): 1623–27. https://doi.org/10.1111/j.1464-410x.2010.09439.x.
       Full Text
    • Kimura, Masaki, Vladimir Mouraviev, Matvey Tsivian, Daniel M. Moreira, Janice M. Mayes, and Thomas J. Polascik. “Analysis of urinary function using validated instruments and uroflowmetry after primary and salvage prostate cryoablation.” Urology 76, no. 5 (November 2010): 1258–65. https://doi.org/10.1016/j.urology.2009.09.062.
       Full Text  Link to Item
    • Tang, Ping, Leon Sun, Matthew A. Uhlman, Cary N. Robertson, Thomas J. Polascik, David M. Albala, Craig F. Donatucci, and Judd W. Moul. “Prostate-specific antigen-based risk-adapted discontinuation of prostate cancer screening in elderly African American and Caucasian American men.” Urology 76, no. 5 (November 2010): 1058–62. https://doi.org/10.1016/j.urology.2009.09.049.
       Full Text  Link to Item
    • Zhai, Liang, John Madden, Wen-Chi Foo, Vladimir Mouraviev, Thomas J. Polascik, Mark L. Palmeri, and Kathryn R. Nightingale. “Characterizing stiffness of human prostates using acoustic radiation force.” Ultrason Imaging 32, no. 4 (October 2010): 201–13. https://doi.org/10.1177/016173461003200401.
       Full Text  Link to Item
    • Caire, Arthur A., Leon Sun, Thomas J. Polascik, David M. Albala, and Judd W. Moul. “Obese African-Americans with prostate cancer (T1c and a prostate-specific antigen, PSA, level of <10 ng/mL) have higher-risk pathological features and a greater risk of PSA recurrence than non-African-Americans.” Bju International 106, no. 8 (October 2010): 1157–60. https://doi.org/10.1111/j.1464-410x.2010.09340.x.
       Full Text
    • Tang, Ping, Leon Sun, Matthew A. Uhlman, Thomas J. Polascik, Stephen J. Freedland, and Judd W. Moul. “Baseline PSA as a predictor of prostate cancer-specific mortality over the past 2 decades: Duke University experience.” Cancer 116, no. 20 (October 2010): 4711–17. https://doi.org/10.1002/cncr.25447.
       Full Text
    • Caire, A. A., L. Sun, B. D. Lack, K. Lum, P. Tang, D. A. Stackhouse, C. N. Robertson, et al. “Predicting non-organ-confined prostate cancer in men diagnosed after 2000.” Prostate Cancer Prostatic Dis 13, no. 3 (September 2010): 248–51. https://doi.org/10.1038/pcan.2010.15.
       Full Text  Link to Item
    • Kimura, Masaki, Zahid Rabbani, Vladimir Mouraviev, Matvey Tsivian, Jorge Caso, Takefumi Satoh, Shiro Baba, et al. “Role of vitamin D(3) as a sensitizer to cryoablation in a murine prostate cancer model: preliminary in vivo study.” Urology 76, no. 3 (September 2010): 764.e14-764.e20. https://doi.org/10.1016/j.urology.2010.03.041.
       Full Text  Link to Item
    • Kimura, Masaki, Zahid Rabbani, Vladimir Mouraviev, Matvey Tsivian, Zeljko Vujaskovic, Takefumi Satoh, Shiro Baba, John M. Baust, John G. Baust, and Thomas J. Polascik. “Morphology of hypoxia following cryoablation in a prostate cancer murine model: its relationship to necrosis, apoptosis and, microvessel density.” Cryobiology 61, no. 1 (August 2010): 148–54. https://doi.org/10.1016/j.cryobiol.2010.06.010.
       Full Text  Link to Item
    • Eggener, Scott, Georg Salomon, Peter T. Scardino, Jean De la Rosette, Thomas J. Polascik, and Simon Brewster. “Focal therapy for prostate cancer: possibilities and limitations.” Eur Urol 58, no. 1 (July 2010): 57–64. https://doi.org/10.1016/j.eururo.2010.03.034.
       Full Text  Link to Item
    • Tsivian, Matvey, Daniel M. Moreira, Jorge R. Caso, Vladimir Mouraviev, John F. Madden, Gennady Bratslavsky, Cary N. Robertson, David M. Albala, and Thomas J. Polascik. “Predicting occult multifocality of renal cell carcinoma.” Eur Urol 58, no. 1 (July 2010): 118–26. https://doi.org/10.1016/j.eururo.2010.03.011.
       Full Text  Link to Item
    • Tsivian, Matvey, Valerie H. Chen, Charles Y. Kim, Dorit E. Zilberman, Vladimir Mouraviev, Rendon C. Nelson, David M. Albala, and Thomas J. Polascik. “Complications of laparoscopic and percutaneous renal cryoablation in a single tertiary referral center.” Eur Urol 58, no. 1 (July 2010): 142–47. https://doi.org/10.1016/j.eururo.2010.03.035.
       Full Text  Link to Item
    • Baust, J. G., D. P. Klossner, R. G. Vanbuskirk, A. A. Gage, V. Mouraviev, T. J. Polascik, and J. M. Baust. “Integrin involvement in freeze resistance of androgen-insensitive prostate cancer.” Prostate Cancer Prostatic Dis 13, no. 2 (June 2010): 151–61. https://doi.org/10.1038/pcan.2009.59.
       Full Text  Link to Item
    • Caire, Arthur A., Leon Sun, Cary N. Robertson, Thomas J. Polascik, Kelly E. Maloney, Daniel J. George, Marva M. Price, et al. “Public survey and survival data do not support recommendations to discontinue prostate-specific antigen screening in men at age 75.” Urology 75, no. 5 (May 2010): 1122–27. https://doi.org/10.1016/j.urology.2009.06.091.
       Full Text  Link to Item
    • Mouraviev, Vladimir, Truls Erik Bjerklund Johansen, and Thomas J. Polascik. “Contemporary results of focal therapy for prostate cancer using cryoablation.” J Endourol 24, no. 5 (May 2010): 827–34. https://doi.org/10.1089/end.2009.0546.
       Full Text  Open Access Copy  Link to Item
    • Rosette, J. de la, H. Ahmed, J. Barentsz, T Bjerklund Johansen, M. Brausi, M. Emberton, F. Frauscher, et al. “Focal therapy in prostate cancer-report from a consensus panel.” J Endourol 24, no. 5 (May 2010): 775–80. https://doi.org/10.1089/end.2009.0596.
       Full Text  Open Access Copy  Link to Item
    • Tsivian, Matvey, Marcel Hruza, Vladimir Mouraviev, Jens Rassweiler, and Thomas J. Polascik. “Prostate biopsy in selecting candidates for hemiablative focal therapy.” J Endourol 24, no. 5 (May 2010): 849–53. https://doi.org/10.1089/end.2009.0473.
       Full Text  Open Access Copy  Link to Item
    • Tsivian, Matvey, and Thomas J. Polascik. “Focal cryotherapy for prostate cancer.” Curr Urol Rep 11, no. 3 (May 2010): 147–51. https://doi.org/10.1007/s11934-010-0100-1.
       Full Text  Link to Item
    • Caso, Jorge R., Vladimir Mouraviev, Matvey Tsivian, Thomas J. Polascik, and Judd W. Moul. “Prostate cancer: an evolving paradigm.” Journal of Endourology 24, no. 5 (May 2010): 805–9. https://doi.org/10.1089/end.2009.0539.
       Full Text  Open Access Copy
    • Choueiri, Toni K., Ming-Hui Chen, Anthony V. D’Amico, Leon Sun, Paul L. Nguyen, Julia H. Hayes, Cary N. Robertson, et al. “Impact of postoperative prostate-specific antigen disease recurrence and the use of salvage therapy on the risk of death.” Cancer 116, no. 8 (April 15, 2010): 1887–92. https://doi.org/10.1002/cncr.25013.
       Full Text  Link to Item
    • Tsivian, Matvey, Masaki Kimura, Leon Sun, Vladimir Mouraviev, Janice M. Mayes, and Thomas J. Polascik. “Predicting unilateral prostate cancer on routine diagnostic biopsy: sextant vs extended.” Bju Int 105, no. 8 (April 2010): 1089–92. https://doi.org/10.1111/j.1464-410X.2009.08904.x.
       Full Text  Link to Item
    • Zhai, Liang, John Madden, Wen-Chi Foo, Mark L. Palmeri, Vladimir Mouraviev, Thomas J. Polascik, and Kathryn R. Nightingale. “Acoustic radiation force impulse imaging of human prostates ex vivo.” Ultrasound Med Biol 36, no. 4 (April 2010): 576–88. https://doi.org/10.1016/j.ultrasmedbio.2009.12.006.
       Full Text  Link to Item
    • Kimura, Masaki, Shiro Baba, and Thomas J. Polascik. “Minimally invasive surgery using ablative modalities for the localized renal mass.” Int J Urol 17, no. 3 (March 2010): 215–27. https://doi.org/10.1111/j.1442-2042.2009.02445.x.
       Full Text  Link to Item
    • Uhlman, Matthew A., Leon Sun, Danielle A. Stackhouse, Thomas J. Polascik, Valdmir Mouraviev, Cary N. Robertson, David M. Albala, and Judd W. Moul. “Tumor percent involvement predicts prostate specific antigen recurrence after radical prostatectomy only in men with smaller prostate.” J Urol 183, no. 3 (March 2010): 997–1001. https://doi.org/10.1016/j.juro.2009.11.046.
       Full Text  Link to Item
    • Tang, Ping, Leon Sun, Matthew A. Uhlman, Cary N. Robertson, Thomas J. Polascik, David M. Albala, Craig F. Donatucci, and Judd W. Moul. “Initial prostate specific antigen 1.5 ng/ml or greater in men 50 years old or younger predicts higher prostate cancer risk.” J Urol 183, no. 3 (March 2010): 946–50. https://doi.org/10.1016/j.juro.2009.11.021.
       Full Text  Link to Item
    • Tsivian, Matvey, John C. Lyne, Janice M. Mayes, Vladimir Mouraviev, Masaki Kimura, and Thomas J. Polascik. “Tumor size and endophytic growth pattern affect recurrence rates after laparoscopic renal cryoablation.” Urology 75, no. 2 (February 2010): 307–10. https://doi.org/10.1016/j.urology.2009.09.039.
       Full Text  Link to Item
    • Uhlman, Matthew A., Leon Sun, Danielle A. Stackhouse, Arthur A. Caire, Thomas J. Polascik, Cary N. Robertson, John Madden, Robin Vollmer, David M. Albala, and Judd W. Moul. “Tumor volume, tumor percentage involvement, or prostate volume: which is predictive of prostate-specific antigen recurrence?” Urology 75, no. 2 (February 2010): 460–66. https://doi.org/10.1016/j.urology.2009.06.059.
       Full Text  Link to Item
    • Tsivian, Matvey, and Thomas J. Polascik. “Recent advances in focal therapy of prostate and kidney cancer.” F1000 Med Rep 2 (January 18, 2010). https://doi.org/10.3410/M2-1.
       Full Text  Link to Item
    • Kimura, Masaki, Vladimir Mouraviev, Matvey Tsivian, Janice M. Mayes, Takefumi Satoh, and Thomas J. Polascik. “Current salvage methods for recurrent prostate cancer after failure of primary radiotherapy.” Bju Int 105, no. 2 (January 2010): 191–201. https://doi.org/10.1111/j.1464-410X.2009.08715.x.
       Full Text  Link to Item
    • Kimura, Masaki, Matvey Tsivian, Vladimir Mouraviev, Janice M. Mayes, Marva M. Price, Michael C. Bannister, John F. Madden, Terence Z. Wong, and Thomas J. Polascik. “Utilization of (111)In-Capromab pendetide SPECT-CT for detecting seminal vesicle invasion with recurrent prostate cancer after primary in situ therapy.” Int J Urol 16, no. 12 (December 2009): 971–75. https://doi.org/10.1111/j.1442-2042.2009.02413.x.
       Full Text  Link to Item
    • Sun, Leon, Arthur A. Caire, Cary N. Robertson, Daniel J. George, Thomas J. Polascik, Kelly E. Maloney, Philip J. Walther, et al. “Men older than 70 years have higher risk prostate cancer and poorer survival in the early and late prostate specific antigen eras.” J Urol 182, no. 5 (November 2009): 2242–48. https://doi.org/10.1016/j.juro.2009.07.034.
       Full Text  Link to Item
    • Tsivian, Matvey, Janice M. Mayes, Tracey L. Krupski, Vladimir Mouraviev, Craig F. Donatucci, and Thomas J. Polascik. “Altered male physiologic function after surgery for prostate cancer: couple perspective.” Int Braz J Urol 35, no. 6 (November 2009): 673–82. https://doi.org/10.1590/s1677-55382009000600006.
       Full Text  Link to Item
    • Tsivian, Matvey, Leon Sun, Vladimir Mouraviev, John F. Madden, Janice M. Mayes, Judd W. Moul, and Thomas J. Polascik. “Changes in Gleason score grading and their effect in predicting outcome after radical prostatectomy.” Urology 74, no. 5 (November 2009): 1090–93. https://doi.org/10.1016/j.urology.2009.03.043.
       Full Text
    • Polascik, Thomas J., and Vladimir Mouraviev. “Focal therapy for prostate cancer is a reasonable treatment option in properly selected patients.” Urology 74, no. 4 (October 2009): 726–30. https://doi.org/10.1016/j.urology.2009.02.084.
       Full Text  Link to Item
    • Polascik, Thomas J. “Bisphosphonates in oncology: evidence for the prevention of skeletal events in patients with bone metastases.” Drug Des Devel Ther 3 (September 21, 2009): 27–40.
       Link to Item
    • Caire, Arthur A., Leon Sun, Oludotun Ode, Danielle A. Stackhouse, Kelly Maloney, Craig Donatucci, Vladimir Mouraviev, et al. “Delayed prostate-specific antigen recurrence after radical prostatectomy: how to identify and what are their clinical outcomes?” Urology 74, no. 3 (September 2009): 643–47. https://doi.org/10.1016/j.urology.2009.02.049.
       Full Text  Link to Item
    • Mouraviev, Vladimir, John F. Madden, Gloria Broadwater, Janice M. Mayes, James L. Burchette, Frank Schneider, Jill Smith, Matvey Tsivian, Terence Wong, and Thomas J. Polascik. “Use of 111in-capromab pendetide immunoscintigraphy to image localized prostate cancer foci within the prostate gland.” J Urol 182, no. 3 (September 2009): 938–47. https://doi.org/10.1016/j.juro.2009.05.047.
       Full Text  Link to Item
    • Xu, David D., Sandy D. Sun, Flint Wang, Leon Sun, Danielle Stackhouse, Thomas Polascik, David M. Albala, Judd W. Moul, Arthur Caire, and Cary N. Robertson. “Effect of age and pathologic Gleason score on PSA recurrence: analysis of 2911 patients undergoing radical prostatectomy.” Urology 74, no. 3 (September 2009): 654–58. https://doi.org/10.1016/j.urology.2008.12.063.
       Full Text  Link to Item
    • D’Alonzo, Richard C., Tong J. Gan, Judd W. Moul, David M. Albala, Thomas J. Polascik, Cary N. Robertson, Leon Sun, Philipp Dahm, and Ashraf S. Habib. “A retrospective comparison of anesthetic management of robot-assisted laparoscopic radical prostatectomy versus radical retropubic prostatectomy.” J Clin Anesth 21, no. 5 (August 2009): 322–28. https://doi.org/10.1016/j.jclinane.2008.09.005.
       Full Text  Link to Item
    • Mayes, J. M., V. Mouraviev, M. Tsivian, T. L. Krupski, C. F. Donatucci, and T. J. Polascik. “Concordance in the perception of couples recovering from primary surgical treatment of prostate cancer.” Int J Impot Res 21, no. 4 (July 2009): 253–60. https://doi.org/10.1038/ijir.2009.23.
       Full Text  Link to Item
    • Stackhouse, Danielle A., Leon Sun, Florian R. Schroeck, Jayakrishnan Jayachandran, Arthur A. Caire, Cyril O. Acholo, Cary N. Robertson, et al. “Factors predicting prostatic biopsy Gleason sum under grading.” J Urol 182, no. 1 (July 2009): 118–22. https://doi.org/10.1016/j.juro.2009.02.127.
       Full Text  Link to Item
    • Habib, Ashraf S., Thomas J. Polascik, Alon Z. Weizer, William D. White, Judd W. Moul, Magdi A. ElGasim, and Tong J. Gan. “Lidocaine patch for postoperative analgesia after radical retropubic prostatectomy.” Anesthesia and Analgesia 108, no. 6 (June 2009): 1950–53. https://doi.org/10.1213/ane.0b013e3181a21185.
       Full Text
    • Polascik, Thomas J., Janice M. Mayes, Florian R. Schroeck, Leon Sun, John F. Madden, Judd W. Moul, and Vladimir Mouraviev. “Patient selection for hemiablative focal therapy of prostate cancer: variables predictive of tumor unilaterality based upon radical prostatectomy.” Cancer 115, no. 10 (May 2009): 2104–10. https://doi.org/10.1002/cncr.24258.
       Full Text
    • Caire, Arthur A., Leon Sun, Thomas J. Polascik, Cary N. Robertson, Kelly E. Maloney, Craig F. Donatucci, Daivd M. Albala, and Judd W. Moul. “PREDICTING NON-ORGAN CONFINED PROSTATE CANCER AFTER THE YEAR 2000.” The Journal of Urology 181, no. 4 (April 2009): 609–609. https://doi.org/10.1016/s0022-5347(09)61710-9.
       Full Text
    • Lack, Benjamin D., Leon Sun, Arthur A. Caire, Craig F. Donatucci, Cary N. Robertson, Vladimir Mouraviev, Thomas J. Polascik, et al. “WHO DOES NOT NEED FOLLOW UP TWO YEARS AFTER PROSTATECTOMY? AN ANALYSIS OF 1739 PATIENTS AT DUKE UNIVERSITY MEDICAL CENTER.” Journal of Urology 181, no. 4S (April 2009): 759–759. https://doi.org/10.1016/s0022-5347(09)62115-7.
       Full Text
    • Lack, Benjamin D., Leon Sun, Arthur A. Caire, Oludotun Ode, Danielle A. Stackhouse, Kelly E. Maloney, Craig F. Donatucci, et al. “DELAYED PSA RECURRENCE AFTER RADICAL PROSTATECTOMY: HOW TO IDENTIFY PATIENTS AT RISK AND THEIR CLINICAL OUTCOMES?” Journal of Urology 181, no. 4S (April 2009): 457–457. https://doi.org/10.1016/s0022-5347(09)61296-9.
       Full Text
    • Moul, Judd W., Leon Sun, Benjamin D. Lack, Cary N. Robertson, Thomas J. Polascik, Craig F. Donatucci, Kelly E. Maloney, Marva Price, David M. Albala, and Arthur A. Caire. “SAY NO TO THE US PREVENTATIVE TASK FORCE RECOMMENDATION TO NO LONGER OFFER PROSTATE CANCER SCREENING AFTER AGE 75?” Journal of Urology 181, no. 4S (April 2009): 797–797. https://doi.org/10.1016/s0022-5347(09)62222-9.
       Full Text
    • Mouraviev, Vladimir, Janice M. Mayes, and Thomas J. Polascik. “Pathologic basis of focal therapy for early-stage prostate cancer.” Nat Rev Urol 6, no. 4 (April 2009): 205–15. https://doi.org/10.1038/nrurol.2009.29.
       Full Text  Link to Item
    • Rosette, J. J. M. C. H. de la, V. Mouraviev, and T. J. Polascik. “Focal Targeted Therapy Will Be a Future Treatment Modality for Early Stage Prostate Cancer.” European Urology, Supplements 8, no. 5 (April 1, 2009): 424–32. https://doi.org/10.1016/j.eursup.2009.01.005.
       Full Text
    • Stackhouse, Danielle A., Leon Sun, Philipp Dahm, Louis R. Kavoussi, David Paulson, Craig F. Donatucci, Kelly E. Maloney, et al. “PERINEAL RADICAL PROSTATECTOMY: WHAT ARE THE TEN YEAR OUTCOMES?” Journal of Urology 181, no. 4S (April 2009): 210–210. https://doi.org/10.1016/s0022-5347(09)60604-2.
       Full Text
    • Chen, Valerie H., Vladimir Mouraviev, Janice M. Mayes, Leon Sun, John F. Madden, Judd W. Moul, and Thomas J. Polascik. “Utility of a 3-dimensional transrectal ultrasound-guided prostate biopsy system for prostate cancer detection.” Technology in Cancer Research & Treatment 8, no. 2 (April 2009): 99–104. https://doi.org/10.1177/153303460900800202.
       Full Text
    • Polascik, Thomas J., Janice M. Mayes, and Vladimir Mouraviev. “Nerve-sparing focal cryoablation of prostate cancer.” Curr Opin Urol 19, no. 2 (March 2009): 182–87. https://doi.org/10.1097/MOU.0b013e328323f603.
       Full Text  Link to Item
    • Moul, Judd W., Vladimir Mouraviev, Leon Sun, Florian R. Schroeck, and Thomas J. Polascik. “Prostate cancer: the new landscape.” Current Opinion in Urology 19, no. 2 (March 2009): 154–60. https://doi.org/10.1097/mou.0b013e328323f5d6.
       Full Text
    • Schroeck, F. R., T. L. Krupski, L. Sun, D. M. Albala, M. M. Price, T. J. Polascik, C. N. Robertson, A. K. Tewari, and J. W. Moul. “Satisfaction and Regret After Open Retropubic or Robot-Assisted Laparoscopic Radical Prostatectomy.” Journal of Urology 181, no. 2 (February 2009): 635–36.
       Link to Item
    • Demark-Wahnefried, Wendy, Thomas J. Polascik, Stephen L. George, Boyd R. Switzer, John F. Madden, Mack T. Ruffin, Denise C. Snyder, et al. “Flaxseed supplementation (not dietary fat restriction) reduces prostate cancer proliferation rates in men presurgery.” Cancer Epidemiol Biomarkers Prev 17, no. 12 (December 2008): 3577–87. https://doi.org/10.1158/1055-9965.EPI-08-0008.
       Full Text  Link to Item
    • Schroeck, Florian R., Craig F. Donatucci, Emily C. Smathers, Leon Sun, David M. Albala, Thomas J. Polascik, Judd W. Moul, and Tracey L. Krupski. “Defining potency: a comparison of the International Index of Erectile Function short version and the Expanded Prostate Cancer Index Composite.” Cancer 113, no. 10 (November 15, 2008): 2687–94. https://doi.org/10.1002/cncr.23887.
       Full Text  Link to Item
    • Stein, Alexandra J., Janice M. Mayes, Vladimir Mouraviev, Valerie H. Chen, Rendon C. Nelson, and Thomas J. Polascik. “Persistent contrast enhancement several months after laparoscopic cryoablation of the small renal mass may not indicate recurrent tumor.” J Endourol 22, no. 11 (November 2008): 2433–39. https://doi.org/10.1089/end.2008.0261.
       Full Text  Link to Item
    • Isariyawongse, Brandon K., Leon Sun, Lionel L. Bañez, Cary Robertson, Thomas J. Polascik, Kelly Maloney, Craig Donatucci, et al. “Significant discrepancies between diagnostic and pathologic Gleason sums in prostate cancer: the predictive role of age and prostate-specific antigen.” Urology 72, no. 4 (October 2008): 882–86. https://doi.org/10.1016/j.urology.2008.02.021.
       Full Text  Link to Item
    • Polascik, Thomas J., Janice M. Mayes, Leon Sun, John F. Madden, Judd W. Moul, and Vladimir Mouraviev. “Pathologic stage T2a and T2b prostate cancer in the recent prostate-specific antigen era: implications for unilateral ablative therapy.” Prostate 68, no. 13 (September 15, 2008): 1380–86. https://doi.org/10.1002/pros.20804.
       Full Text  Link to Item
    • Chen, Valerie H., Janice M. Mayes, Vladimir Mouraviev, and Thomas J. Polascik. “Urothelial sloughing with obstruction after laparoscopic cryoablation of small renal carcinoma in solitary kidney.” Urology 72, no. 3 (September 2008): 716.e1-716.e2. https://doi.org/10.1016/j.urology.2007.12.067.
       Full Text  Link to Item
    • Habib, Ashraf S., William D. White, Magdi A. El Gasim, Gamal Saleh, Thomas J. Polascik, Judd W. Moul, and Tong J. Gan. “Transdermal nicotine for analgesia after radical retropubic prostatectomy.” Anesth Analg 107, no. 3 (September 2008): 999–1004. https://doi.org/10.1213/ane.0b013e31816f2616.
       Full Text  Link to Item
    • Megwalu, Ifeanyichukwu I., Genoa G. Ferguson, John T. Wei, Vladimir Mouraviev, Thomas J. Polascik, Samir Taneja, Linda Black, Gerald L. Andriole, and Adam S. Kibel. “Evaluation of a novel precision template-guided biopsy system for detecting prostate cancer.” Bju Int 102, no. 5 (August 5, 2008): 546–50. https://doi.org/10.1111/j.1464-410X.2008.07832.x.
       Full Text  Link to Item
    • Chen, Valerie H., Janice M. Mayes, John F. Madden, Alexandra J. Stein, Vladimir Mouraviev, and Thomas J. Polascik. “The effect of cryoablation on the histologic interpretation of intraoperative biopsy of small clear cell renal carcinoma and renal oncocytoma.” J Endourol 22, no. 8 (August 2008): 1617–21. https://doi.org/10.1089/end.2008.0156.
       Full Text  Link to Item
    • Mayes, Janice M., Vladimir Mouraviev, and Thomas J. Polascik. “Impact of a cryotherapy training workshop on the adoption and utilization of cryotherapy in the community setting.” Can J Urol 15, no. 4 (August 2008): 4147–52.
       Link to Item
    • Polascik, Thomas J., Janice M. Mayes, and Vladimir Mouraviev. “From whole-gland to targeted cryoablation for the treatment of unilateral or focal prostate cancer.” Oncology (Williston Park) 22, no. 8 (July 2008): 900–906.
       Link to Item
    • Schroeck, Florian R., Leon Sun, Stephen J. Freedland, David M. Albala, Vladimir Mouraviev, Thomas J. Polascik, and Judd W. Moul. “Comparison of prostate-specific antigen recurrence-free survival in a contemporary cohort of patients undergoing either radical retropubic or robot-assisted laparoscopic radical prostatectomy.” Bju Int 102, no. 1 (July 2008): 28–32. https://doi.org/10.1111/j.1464-410X.2008.07607.x.
       Full Text  Link to Item
    • Mouraviev, Vladimir, Gloria Broadwater, Leon Sun, Janice M. Mayes, Judd W. Moul, and Thomas J. Polascik. “Can prostate-specific antigen and prostate-specific antigen velocity be used for prostate cancer screening in men older than 70 years?” Urology 71, no. 6 (June 2008): 1020–23. https://doi.org/10.1016/j.urology.2007.11.016.
       Full Text  Link to Item
    • Koontz, B. F., V. Mouraviev, J. L. Johnson, J. Mayes, S. H. Chen, T. Z. Wong, M. S. Anscher, L. Sun, J. Moul, and T. J. Polascik. “Use of local (111)in-capromab pendetide scan results to predict outcome after salvage radiotherapy for prostate cancer.” International Journal of Radiation Oncology, Biology, Physics 71, no. 2 (June 2008): 358–61.
    • Polascik, Thomas J., and Vladimir Mouraviev. “Focal therapy for prostate cancer.” Curr Opin Urol 18, no. 3 (May 2008): 269–74. https://doi.org/10.1097/MOU.0b013e3282f9b3a5.
       Full Text  Link to Item
    • Polascik, Thomas J., and Vladimir Mouraviev. “Zoledronic acid in the management of metastatic bone disease.” Ther Clin Risk Manag 4, no. 1 (February 2008): 261–68. https://doi.org/10.2147/tcrm.s2707.
       Full Text  Link to Item
    • Demark-Wahnefried, Wendy, Stephen L. George, Boyd R. Switzer, Denise C. Snyder, John F. Madden, Thomas J. Polascik, Mack T. Ruffin, and Robin T. Vollmer. “Overcoming challenges in designing and implementing a phase II randomized controlled trial using a presurgical model to test a dietary intervention in prostate cancer.” Clin Trials 5, no. 3 (2008): 262–72. https://doi.org/10.1177/1740774508091676.
       Full Text  Link to Item
    • Mouraviev, V., and T. J. Polascik. “Avoiding surgery in prostate cancer patients with low-risk disease.” Therapy 5, no. 1 (January 1, 2008): 25–36. https://doi.org/10.2217/14750708.5.1.25.
       Full Text
    • Polascik, T. J. “Bone health in prostate cancer patients receiving androgen-deprivation therapy: the role of bisphosphonates.” Prostate Cancer Prostatic Dis 11, no. 1 (2008): 13–19. https://doi.org/10.1038/sj.pcan.4501019.
       Full Text  Link to Item
    • Mouraviev, Vladimir, Leon Sun, John F. Madden, Janice M. Mayes, Judd W. Moul, and Thomas J. Polascik. “Prostate cancer laterality does not predict prostate-specific antigen recurrence after radical prostatectomy.” Urology 70, no. 6 (December 2007): 1141–45. https://doi.org/10.1016/j.urology.2007.07.066.
       Full Text  Link to Item
    • Polascik, T. J., I. Nosnik, J. M. Mayes, and V. Mouraviev. “Short Term Clinical Outcome after Laparoscopic Cryoablation of the Renal Tumor < or = 3.5 cm.” Technol Cancer Res Treat 6, no. 6 (December 2007): 621–24. https://doi.org/10.1177/153303460700600605.
       Full Text  Link to Item
    • Mouraviev, Vladimir, Janice M. Mayes, Leon Sun, John F. Madden, Judd W. Moul, and Thomas J. Polascik. “Prostate cancer laterality as a rationale of focal ablative therapy for the treatment of clinically localized prostate cancer.” Cancer 110, no. 4 (August 15, 2007): 906–10. https://doi.org/10.1002/cncr.22858.
       Full Text  Link to Item
    • Chen, Stephanie H., Vladimir Mouraviev, Janice M. Mayes, and Thomas J. Polascik. “Prostatic abscess as a delayed complication following cryosurgery for primary prostate cancer.” Can J Urol 14, no. 4 (August 2007): 3646–48.
       Link to Item
    • Polascik, Thomas J., Israel Nosnik, Janice M. Mayes, and Vladimir Mouraviev. “Short-term cancer control after primary cryosurgical ablation for clinically localized prostate cancer using third-generation cryotechnology.” Urology 70, no. 1 (July 2007): 117–21. https://doi.org/10.1016/j.urology.2007.03.027.
       Full Text  Link to Item
    • Chen, Stephanie H., Vladimir Mouraviev, Ganesh V. Raj, Charles G. Marguet, and Thomas J. Polascik. “Ureteropelvic junction obliteration resulting in nephrectomy after radiofrequency ablation of small renal cell carcinoma.” Urology 69, no. 5 (May 2007): 982.e3-982.e5. https://doi.org/10.1016/j.urology.2007.02.031.
       Full Text  Link to Item
    • Marguet, Charles, Ganesh V. Raj, James H. Brashears, Mitchell S. Anscher, Kirk Ludwig, Vladimir Mouraviev, Cary N. Robertson, and Thomas J. Polascik. “Rectourethral fistula after combination radiotherapy for prostate cancer.” Urology 69, no. 5 (May 2007): 898–901. https://doi.org/10.1016/j.urology.2007.01.044.
       Full Text  Link to Item
    • Baust, J. G., A. A. Gage, D. Klossner, D. Clarke, R. Miller, J. Cohen, A. Katz, T. Polascik, H. Clarke, and J. M. Baust. “Issues critical to the successful application of cryosurgical ablation of the prostate.” Technol Cancer Res Treat 6, no. 2 (April 2007): 97–109. https://doi.org/10.1177/153303460700600206.
       Full Text  Link to Item
    • Mouraviev, Vladimir, Janice M. Mayes, John F. Madden, Leon Sun, and Thomas J. Polascik. “Analysis of laterality and percentage of tumor involvement in 1386 prostatectomized specimens for selection of unilateral focal cryotherapy.” Technol Cancer Res Treat 6, no. 2 (April 2007): 91–95. https://doi.org/10.1177/153303460700600205.
       Full Text  Link to Item
    • Sun, Leon, Judd W. Moul, James M. Hotaling, Edward Rampersaud, Phillipp Dahm, Cary Robertson, Nicholas Fitzsimons, David Albala, and Thomas J. Polascik. “Prostate-specific antigen (PSA) and PSA velocity for prostate cancer detection in men aged <50 years.” Bju Int 99, no. 4 (April 2007): 753–57. https://doi.org/10.1111/j.1464-410X.2006.06682.x.
       Full Text  Link to Item
    • Tseng, Timothy Y., Quinton V. Cancel, Susan F. Fesperman, Hubert R. Kuebler, Leon Sun, Cary N. Robertson, Thomas J. Polascik, et al. “The role of early adopter bias for new technologies in robot assisted laparoscopic prostatectomy.” J Urol 177, no. 4 (April 2007): 1318–23. https://doi.org/10.1016/j.juro.2006.11.035.
       Full Text  Link to Item
    • Mouraviev, Vladimir, Israel Nosnik, Cary Robertson, David Albala, Philip Walther, and Thomas J. Polascik. “Comparative financial analysis of minimally invasive surgery to open surgery for small renal tumours < or =3.5 cm: a single institutional experience.” Eur Urol 51, no. 3 (March 2007): 715–20. https://doi.org/10.1016/j.eururo.2006.06.050.
       Full Text  Link to Item
    • Moul, Judd W., Leon Sun, James M. Hotaling, Nicholas J. Fitzsimons, Thomas J. Polascik, Cary N. Robertson, Philipp Dahm, et al. “Age adjusted prostate specific antigen and prostate specific antigen velocity cut points in prostate cancer screening.” J Urol 177, no. 2 (February 2007): 499–503. https://doi.org/10.1016/j.juro.2006.09.063.
       Full Text  Link to Item
    • Mouraviev, Vladimir, Israel Nosnik, Leon Sun, Cary N. Robertson, Philip Walther, David Albala, Judd W. Moul, and Thomas J. Polascik. “Financial comparative analysis of minimally invasive surgery to open surgery for localized prostate cancer: a single-institution experience.” Urology 69, no. 2 (February 2007): 311–14. https://doi.org/10.1016/j.urology.2006.10.025.
       Full Text  Link to Item
    • Mouraviev, Vladimir, Steven Joniau, Hendrik Van Poppel, and Thomas J. Polascik. “Current status of minimally invasive ablative techniques in the treatment of small renal tumours.” Eur Urol 51, no. 2 (February 2007): 328–36. https://doi.org/10.1016/j.eururo.2006.09.024.
       Full Text  Link to Item
    • Auge, Brian K., Robert W. Santa-Cruz, and Thomas J. Polascik. “Effect of freeze time during renal cryoablation: a swine model.” J Endourol 20, no. 12 (December 2006): 1101–5. https://doi.org/10.1089/end.2006.20.1101.
       Full Text  Link to Item
    • Nosnik, Israel P., Vladimir Mouraviev, Rendon Nelson, and Thomas J. Polascik. “Multiple nephron-sparing procedures in solitary kidney with recurrent, metachronous, nonfamilial renal cell carcinoma.” Urology 68, no. 6 (December 2006): 1343.e1-1343.e3. https://doi.org/10.1016/j.urology.2006.09.004.
       Full Text  Link to Item
    • Raj, Ganesh V., Charles Yowell, John F. Madden, Israel Nosnik, Vladimir Mouraviev, and Thomas J. Polascik. “Malignant cystic nephroma.” Can J Urol 13, no. 6 (December 2006): 3348–50.
       Link to Item
    • Mouraviev, Vladimir, and Thomas J. Polascik. “Update on cryotherapy for prostate cancer in 2006.” Curr Opin Urol 16, no. 3 (May 2006): 152–56. https://doi.org/10.1097/01.mou.0000193393.54598.9f.
       Full Text  Link to Item
    • Wiygul, Jeremy B., Costas Lallas, Ari Silverstein, and Thomas J. Polascik. “Ovarian hyperstimulation causing ureteral obstruction in a pregnant woman.” Urology 67, no. 5 (May 2006): 1085.e5-1085.e6. https://doi.org/10.1016/j.urology.2005.11.033.
       Full Text  Link to Item
    • Polascik, T. J. “Preventing bone loss in patients with hormone-sensitive prostate cancer and bone metastases.” American Journal of Urology Review 4, no. 3 (April 1, 2006).
    • Mouraviev, V., B. Evans, and T. J. Polascik. “Salvage prostate cryoablation after primary interstitial brachytherapy failure: a feasible approach.” Prostate Cancer Prostatic Dis 9, no. 1 (2006): 99–101. https://doi.org/10.1038/sj.pcan.4500853.
       Full Text  Link to Item
    • Mouraviev, V., and T. J. Polascik. “Laparoscopic ureteroureterostomy for retrocaval ureter.” European Urology, Supplements 5, no. 5 SPEC. ISS. (January 1, 2006): 466–69. https://doi.org/10.1016/j.eursup.2006.02.011.
       Full Text
    • Weizer, Alon Z., Ganesh V. Raj, Martin O’Connell, Cary N. Robertson, Rendon C. Nelson, and Thomas J. Polascik. “Complications after percutaneous radiofrequency ablation of renal tumors.” Urology 66, no. 6 (December 2005): 1176–80. https://doi.org/10.1016/j.urology.2005.06.125.
       Full Text  Link to Item
    • Polascik, Thomas J., Robert W. Given, Charles Metzger, Sydney R. Julian, James C. Vestal, Gary S. Karlin, Craig S. Barkley, David L. Bilhartz, Laura T. McWhorter, and Leo V. Lacerna. “Open-label trial evaluating the safety and efficacy of zoledronic acid in preventing bone loss in patients with hormone-sensitive prostate cancer and bone metastases.” Urology 66, no. 5 (November 2005): 1054–59. https://doi.org/10.1016/j.urology.2005.05.035.
       Full Text  Link to Item
    • Wiygul, Jeremy B., Brian R. Evans, Bercedis L. Peterson, Thomas J. Polascik, Philip J. Walther, Cary N. Robertson, David M. Albala, and Wendy Demark-Wahnefried. “Supplement use among men with prostate cancer.” Urology 66, no. 1 (July 2005): 161–66. https://doi.org/10.1016/j.urology.2005.01.035.
       Full Text  Link to Item
    • Brashears, James H., Ganesh V. Raj, Alfonso Crisci, Matthew D. Young, Drew Dylewski, Rendon Nelson, John F. Madden, and Thomas J. Polascik. “Renal cryoablation and radio frequency ablation: an evaluation of worst case scenarios in a porcine model.” J Urol 173, no. 6 (June 2005): 2160–65. https://doi.org/10.1097/01.ju.0000158125.80981.f1.
       Full Text  Link to Item
    • Raj, Ganesh V., James H. Brashears, Ankur Anand, David F. Paulson, and Thomas J. Polascik. “Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy?” Urology 65, no. 2 (February 2005): 332–36. https://doi.org/10.1016/j.urology.2004.09.027.
       Full Text  Link to Item
    • Wong, Terence Z., Timothy G. Turkington, Thomas J. Polascik, and R Edward Coleman. “ProstaScint (capromab pendetide) imaging using hybrid gamma camera-CT technology.” Ajr Am J Roentgenol 184, no. 2 (February 2005): 676–80. https://doi.org/10.2214/ajr.184.2.01840676.
       Full Text  Link to Item
    • Dulaimi, Essel, Inmaculada Ibanez de Caceres, Robert G. Uzzo, Tahseen Al-Saleem, Richard E. Greenberg, Thomas J. Polascik, James S. Babb, William E. Grizzle, and Paul Cairns. “Promoter hypermethylation profile of kidney cancer.” Clin Cancer Res 10, no. 12 Pt 1 (June 15, 2004): 3972–79. https://doi.org/10.1158/1078-0432.CCR-04-0175.
       Full Text  Link to Item
    • Demark-Wahnefried, Wendy, Cary N. Robertson, Philip J. Walther, Thomas J. Polascik, David F. Paulson, and Robin T. Vollmer. “Pilot study to explore effects of low-fat, flaxseed-supplemented diet on proliferation of benign prostatic epithelium and prostate-specific antigen.” Urology 63, no. 5 (May 2004): 900–904. https://doi.org/10.1016/j.urology.2003.12.010.
       Full Text  Link to Item
    • Raj, Ganesh V., John F. Madden, and E Everett Anderson. “Liposarcoma presenting as an intraluminal ureteral mass.” Urology 61, no. 5 (May 2003): 1035. https://doi.org/10.1016/s0090-4295(02)02595-5.
       Full Text  Link to Item
    • Santa-Cruz, Robert W., Brian K. Auge, Costas D. Lallas, Glenn M. Preminger, and Thomas J. Polascik. “Use of bipolar laparoscopic forceps to occlude and transect the retroperitoneal vasculature: a porcine model.” J Endourol 17, no. 3 (April 2003): 181–85. https://doi.org/10.1089/089277903321618761.
       Full Text  Link to Item
    • Raj, Ganesh V., Donal J. Reddan, Michael F. Hoey, and Thomas J. Polascik. “Management of small renal tumors with radiofrequency ablation.” Urology 61, no. 1 (January 2003): 23–29. https://doi.org/10.1016/s0090-4295(02)01850-2.
       Full Text  Link to Item
    • Polascik, Thomas J., David G. Bostwick, and Paul Cairns. “Molecular genetics and histopathologic features of adult distal nephron tumors.” Urology 60, no. 6 (December 2002): 941–46. https://doi.org/10.1016/s0090-4295(02)01825-3.
       Full Text  Link to Item
    • Munver, Ravi, Chris B. Threatt, Fernando C. Delvecchio, Glenn M. Preminger, and Thomas J. Polascik. “Hypertonic saline-augmented radiofrequency ablation of the VX-2 tumor implanted in the rabbit kidney: a short-term survival pilot study.” Urology 60, no. 1 (July 2002): 170–75. https://doi.org/10.1016/s0090-4295(02)01667-9.
       Full Text  Link to Item
    • Price, David T., R Edward Coleman, Ray P. Liao, Cary N. Robertson, Thomas J. Polascik, and Timothy R. DeGrado. “Comparison of [18 F]fluorocholine and [18 F]fluorodeoxyglucose for positron emission tomography of androgen dependent and androgen independent prostate cancer.” J Urol 168, no. 1 (July 2002): 273–80.
       Link to Item
    • Raj, Ganesh V., Alan W. Partin, and Thomas J. Polascik. “Clinical utility of indium 111-capromab pendetide immunoscintigraphy in the detection of early, recurrent prostate carcinoma after radical prostatectomy.” Cancer 94, no. 4 (February 15, 2002): 987–96.
       Link to Item
    • Demark-Wahnefried, W., D. T. Price, T. J. Polascik, C. N. Robertson, E. E. Anderson, D. F. Paulson, P. J. Walther, M. Gannon, and R. T. Vollmer. “Pilot study of dietary fat restriction and flaxseed supplementation in men with prostate cancer before surgery: exploring the effects on hormonal levels, prostate-specific antigen, and histopathologic features.” Urology 58, no. 1 (July 2001): 47–52. https://doi.org/10.1016/s0090-4295(01)01014-7.
       Full Text  Link to Item
    • Reddan, D. N., G. V. Raj, and T. J. Polascik. “Management of small renal tumors: an overview.” Am J Med 110, no. 7 (May 2001): 558–62. https://doi.org/10.1016/s0002-9343(01)00650-7.
       Full Text  Link to Item
    • Rosenthal, S. A., M. K. Haseman, and T. J. Polascik. “Utility of capromab pendetide (ProstaScint) imaging in the management of prostate cancer.” Tech Urol 7, no. 1 (March 2001): 27–37.
       Link to Item
    • DeGrado, T. R., R. E. Coleman, S. Wang, S. W. Baldwin, M. D. Orr, C. N. Robertson, T. J. Polascik, and D. T. Price. “Synthesis and evaluation of 18F-labeled choline as an oncologic tracer for positron emission tomography: initial findings in prostate cancer.” Cancer Research 61, no. 1 (January 2001): 110–17.
    • Munver, R., R. C. Donehower, J. D. Kronz, and T. J. Polascik. “HIV infection presenting as an unusually large pure yolk sac tumor of the testis.” J Urol 164, no. 5 (November 2000): 1653–54.
       Link to Item
    • Wolf, J. S., R. Marcovich, I. S. Gill, G. T. Sung, L. R. Kavoussi, R. V. Clayman, E. M. McDougall, et al. “Survey of neuromuscular injuries to the patient and surgeon during urologic laparoscopic surgery.” Urology 55, no. 6 (June 2000): 831–36. https://doi.org/10.1016/s0090-4295(00)00488-x.
       Full Text  Link to Item
    • Haseman, M. K., S. A. Rosenthal, and T. J. Polascik. “Capromab Pendetide imaging of prostate cancer.” Cancer Biother Radiopharm 15, no. 2 (April 2000): 131–40. https://doi.org/10.1089/cbr.2000.15.131.
       Full Text  Link to Item
    • Polascik, T. J., Z. P. Wang, M. Shue, S. Di, R. T. Gurganus, S. C. Hortopan, P. O. Ts’o, and A. W. Partin. “Influence of sextant prostate needle biopsy or surgery on the detection and harvest of intact circulating prostate cancer cells.” J Urol 162, no. 3 Pt 1 (September 1999): 749–52. https://doi.org/10.1097/00005392-199909010-00034.
       Full Text  Link to Item
    • Polascik, T. J., J. E. Oesterling, and A. W. Partin. “Prostate specific antigen: a decade of discovery--what we have learned and where we are going.” J Urol 162, no. 2 (August 1999): 293–306. https://doi.org/10.1016/s0022-5347(05)68543-6.
       Full Text  Link to Item
    • Polascik, T. J., M. J. Manyak, M. K. Haseman, R. T. Gurganus, B. Rogers, R. T. Maguire, and A. W. Partin. “Comparison of clinical staging algorithms and 111indium-capromab pendetide immunoscintigraphy in the prediction of lymph node involvement in high risk prostate carcinoma patients.” Cancer 85, no. 7 (April 1, 1999): 1586–92.
       Link to Item
    • Polascik, T. J., U. Hamper, B. R. Lee, Y. Dai, J. Hilton, C. A. Magee, J. K. Crone, et al. “Ablation of renal tumors in a rabbit model with interstitial saline-augmented radiofrequency energy: preliminary report of a new technology.” Urology 53, no. 3 (March 1999): 465–72. https://doi.org/10.1016/s0090-4295(98)00651-7.
       Full Text  Link to Item
    • Polascik, T. J., A. W. Partin, C. R. Pound, and F. F. Marshall. “Frequent occurrence of metastatic disease in patients with renal cell carcinoma and intrahepatic or supradiaphragmatic intracaval extension treated with surgery: an outcome analysis.” Urology 52, no. 6 (December 1998): 995–99. https://doi.org/10.1016/s0090-4295(98)00367-7.
       Full Text  Link to Item
    • Polascik, T. J., J. D. Pearson, A. W. Partin, and Dr T. J. Polascik. “Use of multivariate models to improve prediction of pathologic stage for men with clinically localized prostate cancer.” Prostate Cancer Prostatic Dis 1, no. 6 (December 1998): 301–6. https://doi.org/10.1038/sj.pcan.4500258.
       Full Text  Link to Item
    • Polascik, T. J., J. D. Pearson, and A. W. Partin. “Multivariate models as predictors of pathological stage using Gleason score, clinical stage, and serum prostate-specific antigen.” Semin Urol Oncol 16, no. 3 (August 1998): 160–71.
       Link to Item
    • Polascik, T. J., and R. N. Chen. “Laparoscopic ureteroureterostomy for retrocaval ureter.” J Urol 160, no. 1 (July 1998): 121–22.
       Link to Item
    • Polascik, T. J., C. R. Pound, T. L. DeWeese, and P. C. Walsh. “Comparison of radical prostatectomy and iodine 125 interstitial radiotherapy for the treatment of clinically localized prostate cancer: a 7-year biochemical (PSA) progression analysis.” Urology 51, no. 6 (June 1998): 884–89.
       Link to Item
    • Steiner, G., P. Cairns, T. J. Polascik, F. F. Marshall, J. I. Epstein, D. Sidransky, and M. Schoenberg. “High-density mapping of chromosomal arm 1q in renal collecting duct carcinoma: region of minimal deletion at 1q32.1-32.2.” Cancer Res 56, no. 21 (November 1, 1996): 5044–46.
       Link to Item
    • Polascik, T. J., K. M. Chan-Tack, R. D. Jeffs, and J. P. Gearhart. “Reappraisal of the role of human chorionic gonadotropin in the diagnosis and treatment of the nonpalpable testis: a 10-year experience.” J Urol 156, no. 2 Pt 2 (August 1996): 804–6. https://doi.org/10.1097/00005392-199608001-00069.
       Full Text  Link to Item
    • Polascik, T. J., P. Cairns, J. I. Epstein, L. Fuzesi, J. Y. Ro, F. F. Marshall, D. Sidransky, and M. Schoenberg. “Distal nephron renal tumors: microsatellite allelotype.” Cancer Res 56, no. 8 (April 15, 1996): 1892–95.
       Link to Item
    • Polascik, T. J., P. Cairns, W. Y. Chang, M. P. Schoenberg, and D. Sidransky. “Distinct regions of allelic loss on chromosome 4 in human primary bladder carcinoma.” Cancer Res 55, no. 22 (November 15, 1995): 5396–99.
       Link to Item
    • Polascik, T. J., M. V. Meng, J. I. Epstein, and F. F. Marshall. “Intraoperative sonography for the evaluation and management of renal tumors: experience with 100 patients.” J Urol 154, no. 5 (November 1995): 1676–80.
       Link to Item
    • Cairns, P., T. J. Polascik, Y. Eby, K. Tokino, J. Califano, A. Merlo, L. Mao, et al. “Frequency of homozygous deletion at p16/CDKN2 in primary human tumours.” Nat Genet 11, no. 2 (October 1995): 210–12. https://doi.org/10.1038/ng1095-210.
       Full Text  Link to Item
    • Polascik, T. J., C. R. Pound, M. V. Meng, A. W. Partin, and F. F. Marshall. “Partial nephrectomy: technique, complications and pathological findings.” J Urol 154, no. 4 (October 1995): 1312–18. https://doi.org/10.1016/s0022-5347(01)66845-9.
       Full Text  Link to Item
    • Chang, W. Y., P. Cairns, M. P. Schoenberg, T. J. Polascik, and D. Sidransky. “Novel suppressor loci on chromosome 14q in primary bladder cancer.” Cancer Research 55, no. 15 (August 1995): 3246–49.
    • Polascik, T. J., and P. C. Walsh. “Radical retropubic prostatectomy: the influence of accessory pudendal arteries on the recovery of sexual function.” J Urol 154, no. 1 (July 1995): 150–52. https://doi.org/10.1016/s0022-5347(01)67252-5.
       Full Text  Link to Item
    • Polascik, T. J., R. G. Moore, M. T. Rosenberg, and L. R. Kavoussi. “Comparison of laparoscopic and open retropubic urethropexy for treatment of stress urinary incontinence.” Urology 45, no. 4 (April 1995): 647–52. https://doi.org/10.1016/S0090-4295(99)80057-0.
       Full Text  Link to Item
    • Riopel, M. A., T. J. Polascik, A. W. Partin, J. Sauvageot, P. C. Walsh, and J. I. Epstein. “Radical prostatectomy in men less than 50 years old.” Urol Oncol 1, no. 2 (March 1995): 80–83. https://doi.org/10.1016/1078-1439(95)00010-f.
       Full Text  Link to Item
    • Elliott, W. J., T. J. Polascik, and M. B. Murphy. “Equivalent antihypertensive effects of combination therapy using diuretic + calcium antagonist compared with diuretic + ACE-inhibitor.” Journal of Human Hypertension 4, no. 6 (December 1990): 717–23.
    • Polascik, T., P. P. Godfrey, and S. P. Watson. “Neomycin cannot be used as a selective inhibitor of inositol phospholipid hydrolysis in intact or semi-permeabilized human platelets. Aminoglycosides activate semi-permeabilized platelets.” Biochemical Journal 243, no. 3 (May 1, 1987): 815–19. https://doi.org/10.1042/bj2430815.
       Full Text

  • Book Sections

    • Tay, K. J., M. Tsivian, and T. J. Polascik. “Prostate cryotherapy.” In Management of Prostate Cancer: A Multidisciplinary Approach, Second Edition, 273–85, 2017. https://doi.org/10.1007/978-3-319-42769-0_18.
       Full Text
    • Mancini, J. G., and T. J. Polascik. “Definitions and principles of focal therapy.” In Technical Aspects of Focal Therapy in Localized Prostate Cancer, 19–28, 2015. https://doi.org/10.1007/978-2-8178-0484-2_3.
       Full Text
    • Rosenzweig, S., Z. Miller, T. Polascik, and K. Nightingale. “Prostate elastography.” In Prostate Ultrasound: Current Practice and Future Directions, 163–72, 2015. https://doi.org/10.1007/978-1-4939-1948-2_12.
       Full Text
    • Mouraviev, V., and T. J. Polascik. “Focal therapy: Prostate hemiablation as the first historical treatment model for focal therapy of early stage prostate cancer.” In Management of Prostate Cancer: Third Edition, 225–41, 2013. https://doi.org/10.1007/978-1-60761-259-9_14.
       Full Text
    • Mouraviev, V., and T. J. Polascik. “Selection criteria for focal therapy of prostate cancer.” In Imaging and Focal Therapy of Early Prostate Cancer, 245–53, 2013. https://doi.org/10.1007/978-1-62703-182-0_18.
       Full Text
    • Polascik, T. J., A. Villers, T. M. Wheeler, D. G. Bostwick, R. Montironi, P. Nevoux, and V. Mouraviev. “Pathologic basis for focal therapy: Understanding cancer grade, volume, and spatial location.” In Imaging and Focal Therapy of Early Prostate Cancer, 53–71, 2013. https://doi.org/10.1007/978-1-62703-182-0_4.
       Full Text
    • Polascik, T. J., and V. Mouraviev. “Roadmap for focal therapy.” In Imaging and Focal Therapy of Early Prostate Cancer, 383–88, 2013. https://doi.org/10.1007/978-1-62703-182-0_28.
       Full Text
    • Tsivian, M., and T. J. Polascik. “Cryotherapy of the Prostate.” In Smith’s Textbook of Endourology: 3rd Edition, 2:1406–15, 2012. https://doi.org/10.1002/9781444345148.ch116.
       Full Text
    • Tsivian, M., and T. J. Polascik. “Cryotherapy.” In Management of Prostate Cancer: A Multidisciplinary Approach, 213–23, 2012. https://doi.org/10.1007/978-3-642-27597-5_16.
       Full Text
    • Mouraviev, V., T. M. Wheeler, and T. J. Polascik. “Histological Trends and the Index Lesion in Localized Prostate Cancer.” In Focal Therapy in Prostate Cancer, 17–28, 2011. https://doi.org/10.1002/9781444346893.ch3.
       Full Text

  • Other Articles

    • Polascik, Thomas J., and Kae Jack Tay. “Editorial Comment.” J Urol, September 2016. https://doi.org/10.1016/j.juro.2016.02.3001.
       Full Text  Link to Item
    • Polascik, Thomas J., Kae Jack Tay, and Judd W. Moul. “Keeping an Open Mind About Novel Concepts for Management of Prostate Cancer.” Eur Urol, December 2015. https://doi.org/10.1016/j.eururo.2015.02.024.
       Full Text  Link to Item
    • Polascik, Thomas J. “Focal therapy of prostate cancer: making steady progress toward a first-line image-guided treatment modality.” Curr Opin Urol, May 2015. https://doi.org/10.1097/MOU.0000000000000171.
       Full Text  Link to Item
    • Passoni, Niccolò M., and Thomas J. Polascik. “Words of wisdom. Re: Tracking the clonal origin of lethal prostate cancer.” Eur Urol, August 2014. https://doi.org/10.1016/j.eururo.2014.05.022.
       Full Text  Link to Item
    • Passoni, Niccolò M., and Thomas J. Polascik. “Targeted prostate biopsies: the complexity behind a simple concept.” Eur Urol, July 2014. https://doi.org/10.1016/j.eururo.2014.03.025.
       Full Text  Link to Item
    • Tsivian, Matvey, Michael R. Abern, and Thomas J. Polascik. “Prostate cancer treatment unblinded.” Lancet Oncol, June 2012. https://doi.org/10.1016/S1470-2045(12)70136-5.
       Full Text  Link to Item
    • Tsivian, Matvey, and Thomas J. Polascik. “Prostate cancer: ideal candidates for focal therapy.” Nat Rev Urol, December 13, 2011. https://doi.org/10.1038/nrurol.2011.206.
       Full Text  Link to Item
    • Tang, P., L. Sun, M. A. Uhlman, C. N. Robertson, T. J. Polascik, and J. W. Moul. “Re: Prostate-specific antigen velocity based risk-adapted discontinuation of prostate cancer screening in elderly men.” Journal of Urology, November 1, 2011. https://doi.org/10.1016/j.juro.2011.07.063.
       Full Text
    • Walsh, Patrick C. “Re: Salvage radiation in men after prostate-specific antigen failure and the risk of death.” J Urol, November 2011. https://doi.org/10.1016/j.juro.2011.08.056.
       Full Text  Link to Item
    • Tsivian, M., J. Caso, M. Kimura, and T. J. Polascik. “Renal function outcomes after laparoscopic renal cryoablation.” International Braz J Urol, July 1, 2011. https://doi.org/10.1590/S1677-55382011000400016.
       Full Text
    • Matvey, Tsivian, and Thomas J. Polascik. “Editorial comment.” Urology, May 2011. https://doi.org/10.1016/j.urology.2010.12.050.
       Full Text  Link to Item
    • Eggener, Scott, Georg Salomon, Peter T. Scardino, Jean De la Rosette, Thomas J. Polascik, and Simon Brewster. “Corrigendum to "Focal Therapy for Prostate Cancer: Possibilities and Limitations" [Eur Urol 2010;58:57-64].” Eur Urol, October 2010. https://doi.org/10.1016/j.eururo.2010.07.001.
       Full Text  Link to Item
    • Tsivian, Matvey, and Thomas J. Polascik. “Editorial comment.” Urology, September 2010. https://doi.org/10.1016/j.urology.2009.12.024.
       Full Text  Link to Item
    • Rosette, Jean de la, Inderbir Gill, and Thomas Polascik. “Focal therapy for prostate and renal cancer--are we ready for it?” J Endourol, May 2010. https://doi.org/10.1089/end.2010.1504.
       Full Text  Link to Item
    • Megwalu, I. I., G. G. Ferguson, J. T. Wei, V. Mouraviev, T. J. Polascik, S. Taneja, L. Black, G. L. Andriole, and A. S. Kibel. “Evaluation of a novel precision template-guided biopsy system for detecting prostate cancer (BJU International (2008) 102 (546-50).” Bju International, July 1, 2009. https://doi.org/10.1111/j.1464-410X.2009.08755.x.
       Full Text
    • Chen, V. H., J. M. Mayes, V. Mouraviev, T. J. Polascik, and Jeffrey A. Cadeddu. “Urothelial Sloughing With Obstruction After Laparoscopic Cryoablation of Small Renal Carcinoma in Solitary Kidney Editoral Comment.” Journal of Urology, April 2009.
       Link to Item
    • Chin, Joseph L. “Editorial Comment.” Journal of Urology. Ovid Technologies (Wolters Kluwer Health), June 2008. https://doi.org/10.1016/j.juro.2008.01.248.
       Full Text
    • Polascik, T. J. “Editorial Comment.” Journal of Urology, June 1, 2008. https://doi.org/10.1016/j.juro.2008.01.250.
       Full Text
    • Mayes, J. M., V. Mouraviev, L. Sun, J. F. Madden, and T. J. Polascik. “WITHDRAWN: Can the conventional sextant prostate biopsy reliably diagnose unilateral prostate cancer in low-risk, localized, prostate cancer?” Prostate Cancer Prostatic Dis, May 13, 2008. https://doi.org/10.1038/pcan.2008.31.
       Full Text  Link to Item
    • Polascik, Thomas J., and Vladimir Mouraviev. “The rise of ablative technologies for treating the small renal mass.” Eur Urol, September 2007. https://doi.org/10.1016/j.eururo.2007.03.005.
       Full Text  Link to Item
    • Mouraviev, V., and T. J. Polascik. “Editorial comment.” Journal of Urology, June 1, 2006. https://doi.org/10.1016/S0022-5347(06)00657-4.
       Full Text
    • Raj, G. V., D. J. Reddan, M. B. Hoey, and T. J. Polascik. “Erratum: Management of Small Renal Tumors with Radiofrequency Ablation (Urology (January 2003) 61 (23-29)).” Urology, July 1, 2004. https://doi.org/10.1016/j.urology.2004.06.002.
       Full Text
    • Zlotta, A. R., and C. C. Schulman. “Ablation of renal tumors in a rabbit model with interstitial saline-augmented radiofrequency energy.” Urology, August 1999.
       Link to Item
    • Polascik, T. J., A. W. Partin, C. R. Pound, and F. F. Marshall. “Long-term survival after radical nephrectomy with intrahepatic or supradiaphragmatic intracaval thrombectomy for renal cell carcinoma.” British Journal of Urology, December 1, 1997.
    • Polascik, T. J., C. R. Pound, M. Z. Meng, A. W. Partin, and F. F. Marshall. “Partial nephrectomy: technique, complications and pathologic findings.” British Journal of Urology, December 1, 1997.

  • Conference Papers

    • Shah, Anand, Thomas J. Polascik, Daniel J. George, John Anderson, Terry Hyslop, Alicia M. Ellis, Andrew J. Armstrong, et al. “Implementation and Impact of a Risk-Stratified Prostate Cancer Screening Algorithm as a Clinical Decision Support Tool in a Primary Care Network.” In J Gen Intern Med, 36:92–99, 2021. https://doi.org/10.1007/s11606-020-06124-2.
       Full Text  Link to Item
    • Chan, D. Y., D. C. Morris, T. Lye, T. J. Polascik, M. L. Palmeri, J. Mamou, and K. R. Nightingale. “Evaluating Image Quality Improvement in Multiparametric Ultrasound Imaging of Prostate Cancer by Combining ARFI, SWEI, B-mode, and QUS.” In Ieee International Ultrasonics Symposium, Ius, Vol. 2020-September, 2020. https://doi.org/10.1109/IUS46767.2020.9251796.
       Full Text
    • Morris, D. C., D. Y. Chan, H. Chen, M. L. Palmeri, T. J. Polascik, W. C. Foo, J. Huang, J. Mamou, and K. R. Nightingale. “Multiparametric Ultrasound for the Targeting of Prostate Cancer using ARFI, SWEI, B-mode, and QUS.” In Ieee International Ultrasonics Symposium, Ius, 2019-October:880–83, 2019. https://doi.org/10.1109/ULTSYM.2019.8926035.
       Full Text
    • Chan, D. Y., S. L. Lipman, M. L. Palmeri, D. C. Morris, T. J. Polascik, N. C. Rouze, and K. R. Nightingale. “Prostate Shear Wave Elastography: Multiresolution Reconstruction Dependence on Push Beam Spacing.” In Ieee International Ultrasonics Symposium, Ius, Vol. 2018-January, 2018. https://doi.org/10.1109/ULTSYM.2018.8580076.
       Full Text
    • Cody Morris, D., D. Y. Chan, M. L. Palmeri, T. J. Glass, M. M. McCormick, K. Jack Tay, T. J. Polascik, R. T. Gupta, and K. R. Nightingale. “Correlation Between 3D ARFI and Quantitative Imaging Metrics from SWEI and Multi-Parametric MRI in Vivo in Normal and Cancerous Prostate Tissue.” In Ieee International Ultrasonics Symposium, Ius, Vol. 2018-January, 2018. https://doi.org/10.1109/ULTSYM.2018.8579729.
       Full Text
    • Palmeri, M., T. Glass, R. Gupta, M. McCormick, A. Brown, T. Polascik, S. Rosenzweig, A. Buck, and K. Nightingale. “Comparison between 3D ARFI imaging and mpMRI in detecting clinically-significant prostate cancer lesions.” In Ieee International Ultrasonics Symposium, Ius, Vol. 2016-November, 2016. https://doi.org/10.1109/ULTSYM.2016.7728618.
       Full Text
    • Miller, Z. A., M. L. Palmeri, S. J. Rosenzweig, T. J. Glass, K. R. Nightingale, T. J. Polascik, A. Buck, and J. Madden. “3D in vivo ARFI imaging: Prostate cancer sensitivity.” In Ieee International Ultrasonics Symposium, Ius, 209–12, 2014. https://doi.org/10.1109/ULTSYM.2014.0053.
       Full Text
    • Rosenzweig, S., N. Rouze, B. Byram, M. Palmeri, T. Polascik, and K. Nightingale. “Bayesian shear wave speed estimation for in vivo 3D imaging of the prostate.” In Ieee International Ultrasonics Symposium, Ius, 1260–63, 2013. https://doi.org/10.1109/ULTSYM.2013.0322.
       Full Text
    • Rosenzweig, S., M. Palmeri, N. Rouze, S. Lipman, E. Kulbacki, J. Madden, T. Polascik, and K. Nightingale. “Comparison of concurrently acquired in vivo 3D ARFI and SWEI images of the prostate.” In Ieee International Ultrasonics Symposium, Ius, 97–100, 2012. https://doi.org/10.1109/ULTSYM.2012.0024.
       Full Text
    • Hsu, C. M. L., T. J. Polascik, M. S. Davenport, C. Kauffman, R. T. Gupta, E. Kulbacki, J. Madden, S. L. Lipman, M. L. Palmeri, and K. R. Nightingale. “Methodology to register prostate B-mode and ARFI images to MR and histology.” In Ieee International Ultrasonics Symposium, Ius, 1866–69, 2011. https://doi.org/10.1109/ULTSYM.2011.0466.
       Full Text
    • Koontz, B. F., L. Gerber, L. L. Bañez, I. T. Degirmenci, Z. Vujaskovic, M. S. Anscher, C. N. Robertson, T. J. Polascik, J. W. Moul, and W. R. Lee. “3D Conformal and Intensity Modulated Radiotherapy to the Prostate Bed have Similar Biochemical Outcomes.” In International Journal of Radiation Oncology*Biology*Physics, 81:S406–7. Elsevier BV, 2011. https://doi.org/10.1016/j.ijrobp.2011.06.659.
       Full Text
    • Koontz, B. F., W. R. Lee, Z. Vujaskovic, M. Carroll, B. P. Quaranta, M. S. Anscher, C. N. Robertson, T. J. Polascik, and J. W. Moul. “Neoadjuvant Radiotherapy plus Prostatectomy for High Risk Prostate Cancer.” In International Journal of Radiation Oncology*Biology*Physics, 81:S397–S397. Elsevier BV, 2011. https://doi.org/10.1016/j.ijrobp.2011.06.640.
       Full Text
    • Wattson, D. A., M. Chen, J. W. Moul, B. J. Moran, D. E. Dosoretz, C. N. Robertson, T. J. Polascik, M. H. Braccioforte, S. A. Salenius, and A. V. D’Amico. “The Number of High-Risk Factors and the Risk of Prostate Cancer-Specific Mortality Following Radical Prostatectomy or Brachytherapy.” In International Journal of Radiation Oncology*Biology*Physics, 81:S434–S434. Elsevier BV, 2011. https://doi.org/10.1016/j.ijrobp.2011.06.716.
       Full Text
    • Calloway, Elizabeth E., David I. Chu, Leah Gerber, Jean-Alfred Thomas, Cary N. Robertson, Thomas J. Polascik, Judd W. Moul, and Lionel L. Bañez. “1204 HEIGHT AND THE RISK FOR AGGRESSIVE PROSTATE CANCER AT THE TIME OF BIOPSY–RESULTS FROM THE DUKE PROSTATE CENTER DATABASE.” In Journal of Urology, Vol. 185. Ovid Technologies (Wolters Kluwer Health), 2011. https://doi.org/10.1016/j.juro.2011.02.839.
       Full Text
    • Gerber, Leah, Lionel L. Bãnez, Stephen J. Freedland, Donghua Xie, Jim J. Qi, Thomas J. Polascik, Cary N. Robertson, and Judd W. Moul. “335 DIABETES MELLITUS AND THE RISK OF HIGH-GRADE PROSTATE CANCER: RESULTS FROM THE DUKE PROSTATE CENTER.” In Journal of Urology, Vol. 185. Ovid Technologies (Wolters Kluwer Health), 2011. https://doi.org/10.1016/j.juro.2011.02.419.
       Full Text
    • Kimura, M., M. Tsivian, J. Caso, D. M. Moreira, V. Mouraviev, C. F. Donatucci, and T. J. Polascik. “ON-DEMAND USE OF ERECTILE AIDS IN MEN WITH SEVERE PREOPERATIVE ERECTILE FUNCTION TREATED BY PROSTATE CRYOABLATION.” In Journal of Sexual Medicine, 8:37–37, 2011.
       Link to Item
    • Kimura, M., B. F. Koontz, H. Yan, Z. Rabbani, T. Satoh, S. Baba, F. Yin, C. F. Donatucci, T. J. Polascik, and Z. Vujaskovic. “A Modern Animal Model of Radiation-induced Erectile Dysfunction.” In International Journal of Radiation Oncology*Biology*Physics, 78:S40–S40. Elsevier BV, 2010. https://doi.org/10.1016/j.ijrobp.2010.07.130.
       Full Text
    • Tsivian, M., C. Y. Kim, J. R. Caso, M. Rosenberg, V. Mouraviev, D. M. Albala, R. Nelson, and T. J. Polascik. “CONTRAST ENHANCEMENT AFTER RENAL CRYOABLATION: AN EVIDENCE OF TREATMENT FAILURE?” In Journal of Endourology, 24:A236–37. MARY ANN LIEBERT INC, 2010.
       Link to Item
    • Tsivian, M., J. R. Caso, M. Kimura, J. F. Madden, T. J. Polascik, and V. Mouraviev. “A NOVEL CO2-LASER PARTIAL NEPHRECTOMY: PILOT STUDY IN A PORCINE MODEL.” In Journal of Endourology, 24:A13–A13. MARY ANN LIEBERT INC, 2010.
       Link to Item
    • Koontz, Bridget F., Brian P. Quaranta, Madelaine Carroll, Zeljko Vujaskovic, W Robert Lee, Cary N. Robertson, Thomas J. Polascik, Mitchell S. Anscher, and Judd W. Moul. “PHASE I TRIAL OF PROSTATECTOMY AFTER PLANNED PRE-OPERATIVE RADIOTHERAPY FOR HIGH RISK LOCALIZED PROSTATE CANCER: PRELIMINARY RESULTS.” In The Journal of Urology, 181:713–713. Ovid Technologies (Wolters Kluwer Health), 2009. https://doi.org/10.1016/s0022-5347(09)61992-3.
       Full Text
    • Shingleton, B., B. Wynia, J. Mayes, M. Tsivian, V. Mouraviev, and T. J. Polascik. “323 LAPAROSCOPIC AND PERCUTANEOUS CRYO ABLATION FOR RENAL TUMORS: A TWO-INSTITUTION EXPERIENCE.” In European Urology Supplements, 8:201–201. Elsevier BV, 2009. https://doi.org/10.1016/s1569-9056(09)60327-4.
       Full Text
    • Zhai, L., J. Madden, V. Mouraviev, T. Polascik, and K. Nightingale. “Correlation between SWEI and ARFI image findings in ex vivo human prostates.” In Proceedings  Ieee Ultrasonics Symposium, 523–26, 2009. https://doi.org/10.1109/ULTSYM.2009.5441796.
       Full Text
    • Zhai, L., J. Dahl, J. Madden, V. Mouraviev, T. Polascik, M. Palmeri, and K. Nightingale. “Three-dimensional acoustic radiation force impulse (ARFI) imaging of human prostates in vivo.” In Proceedings  Ieee Ultrasonics Symposium, 540–43, 2008. https://doi.org/10.ll09/ULTSYM.2008.0131.
       Full Text
    • Moul, Judd W., Leon Sun, Cary N. Robertson, Craig F. Donatucci, David M. Albala, Phillip J. Walther, Vladimir Mouraviev, Florian R. Schroeck, and Thomas J. Polascik. “OLDER MEN ASSOCIATED WITH ADVANCED DISEASE AND POOR OUTCOME: AN ANALYSIS OF 14601 PROSTATE CANCER MEN IN DUKE PROSTATE CENTER.” In Journal of Urology, 179:641–641. Ovid Technologies (Wolters Kluwer Health), 2008. https://doi.org/10.1016/s0022-5347(08)61875-3.
       Full Text
    • Mouraviev, Vladimir, Janice M. Mayes, Laurean Jackson, Alexandra J. Stein, Timothy Haystead, Zeljko Vujaskovic, and Thomas J. Polascik. “NEOADJUVANT DOCETAXEL WITH SUBSEQUENT CYOABLATION OF AN AGGRESSIVE RM-9 MURINE PROSTATE CANCER MODEL IS ASSOCIATED WITH DECREASE IN INTERSTITIAL FLUID PRESSURE AND IMPROVEMENT OF OXYGENATION.” In Journal of Urology, 179:420–420. Ovid Technologies (Wolters Kluwer Health), 2008. https://doi.org/10.1016/s0022-5347(08)61231-8.
       Full Text
    • Sun, Leon, Kevin C. Zorn, David M. Albala, Sergey A. Shikanov, Gregory P. Zagaja, Arieh L. Shalhav, Cary N. Robertson, et al. “PRE-TREATMENT FACTORS PREDICTIVE OF POSITIVE SURGICAL MARGIN IN CONTEMPORARY RADICAL PROSTATECTOMIES.” In Journal of Urology, 179:250–250. Ovid Technologies (Wolters Kluwer Health), 2008. https://doi.org/10.1016/s0022-5347(08)60724-7.
       Full Text
    • Zhai, L., J. Madden, V. Mouraviev, T. Polascik, and K. Nightingale. “Visualizing the anatomic structures of human prostates using Acoustic Radiation Force Impulse (ARFI) imaging.” In Proceedings  Ieee Ultrasonics Symposium, 432–35, 2007. https://doi.org/10.1109/ULTSYM.2007.117.
       Full Text
    • Mayes, Janice M., Vladimir Mouraviev, Israel Nosnik, and Thomas J. Polascik. “The complication rate after cryosurgical ablation for clinically localized prostate cancer using third generation cryotechnology.” In Journal of Endourology, 21:A148–49, 2007.
       Link to Item
    • Mouraviev, Vladimir, Janice M. Mayes, Israel Nosnik, and Thomas J. Polascik. “Short-term cancer control after primary cryosurgical ablation for clinically localized prostate cancer using third generation cryotechnology.” In Journal of Endourology, 21:A149–A149, 2007.
       Link to Item
    • Mouraviev, Vladimir, Leon Sun, John F. Madden, Janice M. Mayes, Judd W. Moul, Daniel J. George, Philip G. Febbo, and Thomas J. Polascik. “Tumor laterality does not predict biochemical prostate cancer recurrence after radical prostatectomy.” In Journal of Endourology, 21:A216–A216. MARY ANN LIEBERT INC, 2007.
       Link to Item
    • Polascik, Thomas J., Israel Nosnik, Janice M. Mayes, and Vladimir Mouraviev. “Financial comparative analysis of minimally invasive surgery to open surgery for small renal tumors less than 3.5 cm: A single institutional experience.” In Journal of Endourology, 21:A115–A115, 2007.
       Link to Item
    • Polascik, Thomas J., Leon Sun, John F. Madden, Janice M. Mayes, Daniel J. George, Philip G. Febbo, and Vladimir Mouraviev. “Prostate cancer laterality as a rationale for the clinical application of focal ablative therapy: An analysis of 1184 prostatectomy specimens.” In Journal of Endourology, 21:A216–A216. MARY ANN LIEBERT INC, 2007.
       Link to Item
    • Polascik, T. J., V. Mouraviev, and I. Nosnik. “Laparoscopic renal cryoablation for tumors less than 3.5 cm.” In Journal of Endourology, 20:A177–A177, 2006.
       Link to Item
    • Proia, Alan D., Leon L. Sun, Kathryn R. Perkinson, Thomas J. Polascik, Vladimir Mouraviev, Craig F. Donatucci, Cary N. Robertson, et al. “262: KI-67: A Potential Prognostic Biomarker for PSA Recurrence?” In Journal of Urology, 175:87–87. Ovid Technologies (Wolters Kluwer Health), 2006. https://doi.org/10.1016/s0022-5347(18)32529-1.
       Full Text
    • Brashears, J. H., A. Crisci, R. C. Nelson, and T. J. Polascik. “Renal radiofrequency ablation: Worst case scenarios in a porcine model.” In American Journal of Roentgenology, 182:14–15. AMER ROENTGEN RAY SOC, 2004.
       Link to Item
    • Demark-Wahnefried, W., T. J. Polascik, C. N. Robertson, P. J. Walther, and D. F. Paulson. “Effects of a low fat, flaxseed-supplemented diet on men with prostatic intraepithelial neoplasia (PIN) or atypia.” In Cancer Epidemiology Biomarkers & Prevention, 11:1171S-1171S. AMER ASSOC CANCER RESEARCH, 2002.
       Link to Item

Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.